<html><head><link rel="stylesheet" type="text/css" href="usc.css"/><title>U.S.C. Title 42 - THE PUBLIC HEALTH AND WELFARE</title></head><body>
<span style="font-weight:bold;font-size:12pt;">42 U.S.C. </span><br/>
<span style="font-size:10pt">United States Code, 2007 Edition</span><br/>
<span style="font-size:10pt">Title 42 - THE PUBLIC HEALTH AND WELFARE</span><br/>
<span style="font-size:10pt">CHAPTER 6A - PUBLIC HEALTH SERVICE</span><br/>
<span style="font-size:10pt">Front Matter</span><br/>
<span style="font-size:10pt">From the U.S. Government Printing Office, <a href="http://www.gpo.gov">www.gpo.gov</a></span><br/><br/>
<!-- field-start:notes -->
<!-- field-start:miscellaneous-note -->
<h4 class="note-head">Part A&mdash;Administration</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">202.</div><div class="two-column-analysis-style-content-right">Administration and supervision of Service.</div></div>
<div><div class="two-column-analysis-style-content-left">203.</div><div class="two-column-analysis-style-content-right">Organization of Service.</div></div>
<div><div class="two-column-analysis-style-content-left">204.</div><div class="two-column-analysis-style-content-right">Commissioned corps; composition; appointment of Regular and Reserve officers; appointment and status of warrant officers.</div></div>
<div><div class="two-column-analysis-style-content-left">204a.</div><div class="two-column-analysis-style-content-right">Deployment readiness.</div></div>
<div><div class="two-column-analysis-style-content-left">205.</div><div class="two-column-analysis-style-content-right">Appointment and tenure of office of Surgeon General; reversion in rank.</div></div>
<div><div class="two-column-analysis-style-content-left">206.</div><div class="two-column-analysis-style-content-right">Assignment of officers.</div></div>
<div><div class="two-column-analysis-style-content-left">207.</div><div class="two-column-analysis-style-content-right">Grades, ranks, and titles of commissioned corps.</div></div>
<div><div class="two-column-analysis-style-content-left">208.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">209.</div><div class="two-column-analysis-style-content-right">Appointment of personnel.</div></div>
<div><div class="two-column-analysis-style-content-left">209a to 209c.</div><div class="two-column-analysis-style-content-right" id="wide">Omitted or Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">209d.</div><div class="two-column-analysis-style-content-right">Appointment of osteopaths as commissioned officers.</div></div>
<div><div class="two-column-analysis-style-content-left">210.</div><div class="two-column-analysis-style-content-right">Pay and allowances.</div></div>
<div><div class="two-column-analysis-style-content-left">210&ndash;1.</div><div class="two-column-analysis-style-content-right">Annual and sick leave.</div></div>
<div><div class="two-column-analysis-style-content-left">210a.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">210b.</div><div class="two-column-analysis-style-content-right">Professional categories.</div></div>
<div><div class="two-column-analysis-style-content-left">211.</div><div class="two-column-analysis-style-content-right">Promotion of commissioned officers.</div></div>
<div><div class="two-column-analysis-style-content-left">211a, 211b.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">211c.</div><div class="two-column-analysis-style-content-right">Promotion credit for medical officers in assistant grade.</div></div>
<div><div class="two-column-analysis-style-content-left">212.</div><div class="two-column-analysis-style-content-right">Retirement of commissioned officers.</div></div>
<div><div class="two-column-analysis-style-content-left">212a, 212b.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">213.</div><div class="two-column-analysis-style-content-right">Military benefits.</div></div>
<div><div class="two-column-analysis-style-content-left">213a.</div><div class="two-column-analysis-style-content-right">Rights, benefits, privileges, and immunities for commissioned officers or beneficiaries; exercise of authority by Secretary or designee.<!-- PDFPage:15 --></div></div>
<div><div class="two-column-analysis-style-content-left">214.</div><div class="two-column-analysis-style-content-right">Presentation of United States flag upon retirement.</div></div>
<div><div class="two-column-analysis-style-content-left">214a.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">215.</div><div class="two-column-analysis-style-content-right">Detail of Service personnel.</div></div>
<div><div class="two-column-analysis-style-content-left">216.</div><div class="two-column-analysis-style-content-right">Regulations.</div></div>
<div><div class="two-column-analysis-style-content-left">217.</div><div class="two-column-analysis-style-content-right">Use of Service in time of war or emergency.</div></div>
<div><div class="two-column-analysis-style-content-left">217a.</div><div class="two-column-analysis-style-content-right">Advisory councils or committees.</div></div>
<div><div class="two-column-analysis-style-content-left">217a&ndash;1.</div><div class="two-column-analysis-style-content-right">Advisory committees; prohibition of consideration of political affiliations.</div></div>
<div><div class="two-column-analysis-style-content-left">217b.</div><div class="two-column-analysis-style-content-right">Volunteer services.</div></div>
<div><div class="two-column-analysis-style-content-left">218.</div><div class="two-column-analysis-style-content-right">National Advisory Councils on Migrant Health.</div></div>
<div><div class="two-column-analysis-style-content-left">218a.</div><div class="two-column-analysis-style-content-right">Training of officers.</div></div>
<div><div class="two-column-analysis-style-content-left">219 to 230.</div><div class="two-column-analysis-style-content-right" id="wide">Transferred, Repealed, or Omitted.</div></div>
<div><div class="two-column-analysis-style-content-left">231.</div><div class="two-column-analysis-style-content-right">Service and supply fund; uses; reimbursement.</div></div>
<div><div class="two-column-analysis-style-content-left">232.</div><div class="two-column-analysis-style-content-right">National Institute of Mental Health; authorization of appropriation; construction; location.</div></div>
<div><div class="two-column-analysis-style-content-left">233.</div><div class="two-column-analysis-style-content-right">Civil actions or proceedings against commissioned officers or employees.</div></div>
<div><div class="two-column-analysis-style-content-left">234.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">235.</div><div class="two-column-analysis-style-content-right">Administration of grants in multigrant projects; promulgation of regulations.</div></div>
<div><div class="two-column-analysis-style-content-left">236.</div><div class="two-column-analysis-style-content-right">Orphan Products Board.</div></div>
<div><div class="two-column-analysis-style-content-left">237.</div><div class="two-column-analysis-style-content-right">Silvio O. Conte Senior Biomedical Research Service.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part B&mdash;Miscellaneous Provisions</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">238.</div><div class="two-column-analysis-style-content-right">Gifts for benefit of Service.</div></div>
<div><div class="two-column-analysis-style-content-left">238a.</div><div class="two-column-analysis-style-content-right">Use of immigration station hospitals.</div></div>
<div><div class="two-column-analysis-style-content-left">238b.</div><div class="two-column-analysis-style-content-right">Disposition of money collected for care of patients.</div></div>
<div><div class="two-column-analysis-style-content-left">238c.</div><div class="two-column-analysis-style-content-right">Transportation of remains of officers.</div></div>
<div><div class="two-column-analysis-style-content-left">238d.</div><div class="two-column-analysis-style-content-right">Availability of appropriations for grants to Federal institutions.</div></div>
<div><div class="two-column-analysis-style-content-left">238e.</div><div class="two-column-analysis-style-content-right">Transfer of funds.</div></div>
<div><div class="two-column-analysis-style-content-left">238f.</div><div class="two-column-analysis-style-content-right">Availability of appropriations.</div></div>
<div><div class="two-column-analysis-style-content-left">238g.</div><div class="two-column-analysis-style-content-right">Wearing of uniforms.</div></div>
<div><div class="two-column-analysis-style-content-left">238h.</div><div class="two-column-analysis-style-content-right">Biennial report.</div></div>
<div><div class="two-column-analysis-style-content-left">238i.</div><div class="two-column-analysis-style-content-right">Memorials and other acknowledgments for contributions to health of Nation.</div></div>
<div><div class="two-column-analysis-style-content-left">238j.</div><div class="two-column-analysis-style-content-right">Evaluation of programs.</div></div>
<div><div class="two-column-analysis-style-content-left">238k.</div><div class="two-column-analysis-style-content-right">Contract authority.</div></div>
<div><div class="two-column-analysis-style-content-left">238<em>l.</em></div><div class="two-column-analysis-style-content-right">Recovery.</div></div>
<div><div class="two-column-analysis-style-content-left">238m.</div><div class="two-column-analysis-style-content-right">Use of fiscal agents.</div></div>
<div><div class="two-column-analysis-style-content-left">238n.</div><div class="two-column-analysis-style-content-right">Abortion-related discrimination in governmental activities regarding training and licensing of physicians.</div></div>
<div><div class="two-column-analysis-style-content-left">238<em>o.</em></div><div class="two-column-analysis-style-content-right">Restriction on use of funds for assisted suicide, euthanasia, and mercy killing.</div></div>
<div><div class="two-column-analysis-style-content-left">238p.</div><div class="two-column-analysis-style-content-right">Recommendations and guidelines regarding automated external defibrillators for Federal buildings.</div></div>
<div><div class="two-column-analysis-style-content-left">238q.</div><div class="two-column-analysis-style-content-right">Liability regarding emergency use of automated external defibrillators.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part C&mdash;Smallpox Emergency Personnel Protection</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">239.</div><div class="two-column-analysis-style-content-right">General provisions.</div></div>
<div><div class="two-column-analysis-style-content-left">239a.</div><div class="two-column-analysis-style-content-right">Determination of eligibility and benefits.</div></div>
<div><div class="two-column-analysis-style-content-left">239b.</div><div class="two-column-analysis-style-content-right">Smallpox vaccine injury table.</div></div>
<div><div class="two-column-analysis-style-content-left">239c.</div><div class="two-column-analysis-style-content-right">Medical benefits.</div></div>
<div><div class="two-column-analysis-style-content-left">239d.</div><div class="two-column-analysis-style-content-right">Compensation for lost employment income.</div></div>
<div><div class="two-column-analysis-style-content-left">239e.</div><div class="two-column-analysis-style-content-right">Payment for death.</div></div>
<div><div class="two-column-analysis-style-content-left">239f.</div><div class="two-column-analysis-style-content-right">Administration.</div></div>
<div><div class="two-column-analysis-style-content-left">239g.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations.</div></div>
<div><div class="two-column-analysis-style-content-left">239h.</div><div class="two-column-analysis-style-content-right">Relationship to other laws.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="analysis-subhead">SUBCHAPTER II&mdash;GENERAL POWERS AND DUTIES</h4>
<h4 class="note-head">Part A&mdash;Research and Investigations</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">241.</div><div class="two-column-analysis-style-content-right">Research and investigations generally.</div></div>
<div><div class="two-column-analysis-style-content-left">242.</div><div class="two-column-analysis-style-content-right">Studies and investigations on use and misuse of narcotic drugs and other drugs; annual report to Attorney General; cooperation with States.</div></div>
<div><div class="two-column-analysis-style-content-left">242a.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">242b.</div><div class="two-column-analysis-style-content-right">General authority respecting research, evaluations, and demonstrations in health statistics, health services, and health care technology.</div></div>
<div><div class="two-column-analysis-style-content-left">242c to 242j.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed or Transferred.</div></div>
<div><div class="two-column-analysis-style-content-left">242k.</div><div class="two-column-analysis-style-content-right">National Center for Health Statistics.</div></div>
<div><div class="two-column-analysis-style-content-left">242<em>l.</em></div><div class="two-column-analysis-style-content-right">International cooperation.</div></div>
<div><div class="two-column-analysis-style-content-left">242m.</div><div class="two-column-analysis-style-content-right">General provisions respecting effectiveness, efficiency, and quality of health services.</div></div>
<div><div class="two-column-analysis-style-content-left">242n.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">242<em>o.</em></div><div class="two-column-analysis-style-content-right">Health conferences; publication of health educational information.</div></div>
<div><div class="two-column-analysis-style-content-left">242p.</div><div class="two-column-analysis-style-content-right">National disease prevention data profile.</div></div>
<div><div class="two-column-analysis-style-content-left">242q.</div><div class="two-column-analysis-style-content-right">Task Force on Aging Research; establishment and duties.</div></div>
<div><div class="two-column-analysis-style-content-left">242q&ndash;1.</div><div class="two-column-analysis-style-content-right">Membership.</div></div>
<div><div class="two-column-analysis-style-content-left">242q&ndash;2.</div><div class="two-column-analysis-style-content-right">Administrative staff and support.</div></div>
<div><div class="two-column-analysis-style-content-left">242q&ndash;3.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">242q&ndash;4.</div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
<div><div class="two-column-analysis-style-content-left">242q&ndash;5.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations.</div></div>
<div><div class="two-column-analysis-style-content-left">242r.</div><div class="two-column-analysis-style-content-right">Improvement and publication of data on food-related allergic responses.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part B&mdash;Federal-State Cooperation</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">243.</div><div class="two-column-analysis-style-content-right">General grant of authority for cooperation.</div></div>
<div><div class="two-column-analysis-style-content-left">244.</div><div class="two-column-analysis-style-content-right">Public access defibrillation programs.</div></div>
<div><div class="two-column-analysis-style-content-left">244&ndash;1, 244a.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">245.</div><div class="two-column-analysis-style-content-right">Public access defibrillation demonstration projects.</div></div>
<div><div class="two-column-analysis-style-content-left">245a.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">246.</div><div class="two-column-analysis-style-content-right">Grants and services to States.</div></div>
<div><div class="two-column-analysis-style-content-left">246a.</div><div class="two-column-analysis-style-content-right">Bureau of State Services management fund; establishment; advancements; availability.</div></div>
<div><div class="two-column-analysis-style-content-left">247.</div><div class="two-column-analysis-style-content-right" id="wide">Omitted.</div></div>
<div><div class="two-column-analysis-style-content-left">247a.</div><div class="two-column-analysis-style-content-right">Family support groups for Alzheimer's disease patients.</div></div>
<div><div class="two-column-analysis-style-content-left">247b.</div><div class="two-column-analysis-style-content-right">Project grants for preventive health services.</div></div>
<div><div class="two-column-analysis-style-content-left">247b&ndash;1.</div><div class="two-column-analysis-style-content-right">Screenings, referrals, and education regarding lead poisoning.</div></div>
<div><div class="two-column-analysis-style-content-left">247b&ndash;2.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">247b&ndash;3.</div><div class="two-column-analysis-style-content-right">Education, technology assessment, and epidemiology regarding lead poisoning.</div></div>
<div><div class="two-column-analysis-style-content-left">247b&ndash;3a.</div><div class="two-column-analysis-style-content-right">Training and reports by the Health Resources and Services Administration.</div></div>
<div><div class="two-column-analysis-style-content-left">247b&ndash;4.</div><div class="two-column-analysis-style-content-right">National Center on Birth Defects and Developmental Disabilities.</div></div>
<div><div class="two-column-analysis-style-content-left">247b&ndash;4a.</div><div class="two-column-analysis-style-content-right">Early detection, diagnosis, and interventions for newborns and infants with hearing loss.</div></div>
<div><div class="two-column-analysis-style-content-left" id="wide">247b&ndash;4b to 247b&ndash;4e. Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">247b&ndash;4f.</div><div class="two-column-analysis-style-content-right">Research relating to preterm labor and delivery and the care, treatment, and outcomes of preterm and low birthweight infants.</div></div>
<div><div class="two-column-analysis-style-content-left">247b&ndash;4g.</div><div class="two-column-analysis-style-content-right">Interagency Coordinating Council on Prematurity and Low Birthweight.</div></div>
<div><div class="two-column-analysis-style-content-left">247b&ndash;5.</div><div class="two-column-analysis-style-content-right">Preventive health measures with respect to prostate cancer.</div></div>
<div><div class="two-column-analysis-style-content-left">247b&ndash;6.</div><div class="two-column-analysis-style-content-right">Preventive health services regarding tuberculosis.</div></div>
<div><div class="two-column-analysis-style-content-left">247b&ndash;7.</div><div class="two-column-analysis-style-content-right">Loan repayment program.</div></div>
<div><div class="two-column-analysis-style-content-left">247b&ndash;8.</div><div class="two-column-analysis-style-content-right">Fellowship and training programs.</div></div>
<div><div class="two-column-analysis-style-content-left">247b&ndash;9.</div><div class="two-column-analysis-style-content-right">Diabetes in children and youth.</div></div>
<div><div class="two-column-analysis-style-content-left">247b&ndash;10.</div><div class="two-column-analysis-style-content-right">Compilation of data on asthma.</div></div>
<div><div class="two-column-analysis-style-content-left">247b&ndash;11.</div><div class="two-column-analysis-style-content-right">Effects of folic acid in prevention of birth defects.</div></div>
<div><div class="two-column-analysis-style-content-left">247b&ndash;12.</div><div class="two-column-analysis-style-content-right">Safe motherhood.</div></div>
<div><div class="two-column-analysis-style-content-left">247b&ndash;13.</div><div class="two-column-analysis-style-content-right">Prenatal and postnatal health.</div></div>
<div><div class="two-column-analysis-style-content-left">247b&ndash;14.</div><div class="two-column-analysis-style-content-right">Oral health promotion and disease prevention.</div></div>
<div><div class="two-column-analysis-style-content-left">247b&ndash;14a.</div><div class="two-column-analysis-style-content-right">Identification of interventions that reduce the burden and transmission of oral, dental, and craniofacial diseases in high risk populations; development of approaches for pediatric oral and craniofacial assessment.<!-- PDFPage:16 --></div></div>
<div><div class="two-column-analysis-style-content-left">247b&ndash;15.</div><div class="two-column-analysis-style-content-right">Surveillance and education regarding hepatitis C virus.</div></div>
<div><div class="two-column-analysis-style-content-left">247b&ndash;16.</div><div class="two-column-analysis-style-content-right">Grants for lead poisoning related activities.</div></div>
<div><div class="two-column-analysis-style-content-left">247b&ndash;17.</div><div class="two-column-analysis-style-content-right">Human papillomavirus (Johanna's Law).</div></div>
<div><div class="two-column-analysis-style-content-left">247b&ndash;18.</div><div class="two-column-analysis-style-content-right">Surveillance and research regarding muscular dystrophy.</div></div>
<div><div class="two-column-analysis-style-content-left">247b&ndash;19.</div><div class="two-column-analysis-style-content-right">Information and education.</div></div>
<div><div class="two-column-analysis-style-content-left">247b&ndash;20.</div><div class="two-column-analysis-style-content-right">Food safety grants.</div></div>
<div><div class="two-column-analysis-style-content-left">247b&ndash;21.</div><div class="two-column-analysis-style-content-right">Mosquito-borne diseases; coordination grants to States; assessment and control grants to political subdivisions.</div></div>
<div><div class="two-column-analysis-style-content-left">247c.</div><div class="two-column-analysis-style-content-right">Sexually transmitted diseases; prevention and control projects and programs.</div></div>
<div><div class="two-column-analysis-style-content-left">247c&ndash;1.</div><div class="two-column-analysis-style-content-right">Infertility and sexually transmitted diseases.</div></div>
<div><div class="two-column-analysis-style-content-left">247c&ndash;2.</div><div class="two-column-analysis-style-content-right">Data collection regarding programs under subchapter XXIV.</div></div>
<div><div class="two-column-analysis-style-content-left">247d.</div><div class="two-column-analysis-style-content-right">Public health emergencies.</div></div>
<div><div class="two-column-analysis-style-content-left">247d&ndash;1.</div><div class="two-column-analysis-style-content-right">Vaccine tracking and distribution.</div></div>
<div><div class="two-column-analysis-style-content-left">247d&ndash;2, 247d&ndash;3.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">247d&ndash;3a.</div><div class="two-column-analysis-style-content-right">Improving State and local public health security.</div></div>
<div><div class="two-column-analysis-style-content-left">247d&ndash;3b.</div><div class="two-column-analysis-style-content-right">Partnerships for State and regional hospital preparedness to improve surge capacity.</div></div>
<div><div class="two-column-analysis-style-content-left">247d&ndash;4.</div><div class="two-column-analysis-style-content-right">Revitalizing the Centers for Disease Control and Prevention.</div></div>
<div><div class="two-column-analysis-style-content-left">247d&ndash;5.</div><div class="two-column-analysis-style-content-right">Combating antimicrobial resistance.</div></div>
<div><div class="two-column-analysis-style-content-left">247d&ndash;5a.</div><div class="two-column-analysis-style-content-right">Identification of clinically susceptible concentrations of antimicrobials.</div></div>
<div><div class="two-column-analysis-style-content-left">247d&ndash;6.</div><div class="two-column-analysis-style-content-right">Public health countermeasures to a bioterrorist attack.</div></div>
<div><div class="two-column-analysis-style-content-left">247d&ndash;6a.</div><div class="two-column-analysis-style-content-right">Authority for use of certain procedures regarding qualified countermeasure research and development activities.</div></div>
<div><div class="two-column-analysis-style-content-left">247d&ndash;6b.</div><div class="two-column-analysis-style-content-right">Strategic National Stockpile and security countermeasure procurements.</div></div>
<div><div class="two-column-analysis-style-content-left">247d&ndash;6c.</div><div class="two-column-analysis-style-content-right">Reports regarding authorities under this Act.</div></div>
<div><div class="two-column-analysis-style-content-left">247d&ndash;6d.</div><div class="two-column-analysis-style-content-right">Targeted liability protections for pandemic and epidemic products and security countermeasures.</div></div>
<div><div class="two-column-analysis-style-content-left">247d&ndash;6e.</div><div class="two-column-analysis-style-content-right">Covered countermeasure process.</div></div>
<div><div class="two-column-analysis-style-content-left">247d&ndash;7.</div><div class="two-column-analysis-style-content-right">Demonstration program to enhance bioterrorism training, coordination, and readiness.</div></div>
<div><div class="two-column-analysis-style-content-left">247d&ndash;7a.</div><div class="two-column-analysis-style-content-right">Grants regarding training and education of certain health professionals.</div></div>
<div><div class="two-column-analysis-style-content-left">247d&ndash;7b.</div><div class="two-column-analysis-style-content-right">Emergency system for advance registration of health professions volunteers.</div></div>
<div><div class="two-column-analysis-style-content-left">247d&ndash;7c.</div><div class="two-column-analysis-style-content-right">Supplies and services in lieu of award funds.</div></div>
<div><div class="two-column-analysis-style-content-left">247d&ndash;7d.</div><div class="two-column-analysis-style-content-right">Security for countermeasure development and production.</div></div>
<div><div class="two-column-analysis-style-content-left">247d&ndash;7e.</div><div class="two-column-analysis-style-content-right">Biomedical Advanced Research and Development Authority.</div></div>
<div><div class="two-column-analysis-style-content-left">247d&ndash;7f.</div><div class="two-column-analysis-style-content-right">National Biodefense Science Board and working groups.</div></div>
<div><div class="two-column-analysis-style-content-left">247d&ndash;8.</div><div class="two-column-analysis-style-content-right">Coordinated program to improve pediatric oral health.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part C&mdash;Hospitals, Medical Examinations, and Medical Care</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">247e.</div><div class="two-column-analysis-style-content-right">National Hansen's Disease Programs Center.</div></div>
<div><div class="two-column-analysis-style-content-left">248.</div><div class="two-column-analysis-style-content-right">Control and management of hospitals; furnishing prosthetic and orthopedic devices; transfer of patients; disposal of articles produced by patients; disposal of money and effects of deceased patients; payment of burial expenses.</div></div>
<div><div class="two-column-analysis-style-content-left">248a.</div><div class="two-column-analysis-style-content-right">Closing or transfer of hospitals; reduction of services; Congressional authorization required.</div></div>
<div><div class="two-column-analysis-style-content-left">248b.</div><div class="two-column-analysis-style-content-right">Transfer or financial self-sufficiency of public health service hospitals and clinics.</div></div>
<div><div class="two-column-analysis-style-content-left">248c, 248d.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">249.</div><div class="two-column-analysis-style-content-right">Medical care and treatment of quarantined and detained persons.</div></div>
<div><div class="two-column-analysis-style-content-left">250.</div><div class="two-column-analysis-style-content-right">Medical care and treatment of Federal prisoners.</div></div>
<div><div class="two-column-analysis-style-content-left">250a.</div><div class="two-column-analysis-style-content-right">Transfer of appropriations.</div></div>
<div><div class="two-column-analysis-style-content-left">251.</div><div class="two-column-analysis-style-content-right">Medical examination and treatment of Federal employees; medical care at remote stations.</div></div>
<div><div class="two-column-analysis-style-content-left">252.</div><div class="two-column-analysis-style-content-right">Medical examination of aliens.</div></div>
<div><div class="two-column-analysis-style-content-left">253.</div><div class="two-column-analysis-style-content-right">Medical services to Coast Guard, National Oceanic and Atmospheric Administration, and Public Health Service.</div></div>
<div><div class="two-column-analysis-style-content-left">253a.</div><div class="two-column-analysis-style-content-right">Medical services to retired personnel of National Oceanic and Atmospheric Administration.</div></div>
<div><div class="two-column-analysis-style-content-left">253b.</div><div class="two-column-analysis-style-content-right">Former Lighthouse Service employees; medical service eligibility.</div></div>
<div><div class="two-column-analysis-style-content-left">254.</div><div class="two-column-analysis-style-content-right">Interdepartmental work.</div></div>
<div><div class="two-column-analysis-style-content-left">254a.</div><div class="two-column-analysis-style-content-right">Sharing of medical care facilities and resources.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part D&mdash;Primary Health Care</h4>
I74subpart i&mdash;health centers<div class="analysis">
<div><div class="two-column-analysis-style-content-left">254b.</div><div class="two-column-analysis-style-content-right">Health centers.</div></div>
<div><div class="two-column-analysis-style-content-left">254c.</div><div class="two-column-analysis-style-content-right">Rural health care services outreach, rural health network development, and small health care provider quality improvement grant programs.</div></div>
<div><div class="two-column-analysis-style-content-left">254c&ndash;1.</div><div class="two-column-analysis-style-content-right">Grants for health services for Pacific Islanders.</div></div>
<div><div class="two-column-analysis-style-content-left">254c&ndash;2.</div><div class="two-column-analysis-style-content-right">Special diabetes programs for type I diabetes.</div></div>
<div><div class="two-column-analysis-style-content-left">254c&ndash;3.</div><div class="two-column-analysis-style-content-right">Special diabetes programs for Indians.</div></div>
<div><div class="two-column-analysis-style-content-left">254c&ndash;4.</div><div class="two-column-analysis-style-content-right">Centers for strategies on facilitating utilization of preventive health services among various populations.</div></div>
<div><div class="two-column-analysis-style-content-left">254c&ndash;5.</div><div class="two-column-analysis-style-content-right">Epilepsy; seizure disorder.</div></div>
<div><div class="two-column-analysis-style-content-left">254c&ndash;6.</div><div class="two-column-analysis-style-content-right">Certain services for pregnant women.</div></div>
<div><div class="two-column-analysis-style-content-left">254c&ndash;7.</div><div class="two-column-analysis-style-content-right">Special needs adoption programs; public awareness campaign and other activities.</div></div>
<div><div class="two-column-analysis-style-content-left">254c&ndash;8.</div><div class="two-column-analysis-style-content-right">Healthy start for infants.</div></div>
<div><div class="two-column-analysis-style-content-left">254c&ndash;9.</div><div class="two-column-analysis-style-content-right">Establishment of program of grants.</div></div>
<div><div class="two-column-analysis-style-content-left">254c&ndash;10.</div><div class="two-column-analysis-style-content-right">Certain requirements.</div></div>
<div><div class="two-column-analysis-style-content-left">254c&ndash;11.</div><div class="two-column-analysis-style-content-right">Technical assistance.</div></div>
<div><div class="two-column-analysis-style-content-left">254c&ndash;12.</div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
<div><div class="two-column-analysis-style-content-left">254c&ndash;13.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations.</div></div>
<div><div class="two-column-analysis-style-content-left">254c&ndash;14.</div><div class="two-column-analysis-style-content-right">Telehealth network and telehealth resource centers grant programs.</div></div>
<div><div class="two-column-analysis-style-content-left">254c&ndash;15.</div><div class="two-column-analysis-style-content-right">Rural emergency medical service training and equipment assistance program.</div></div>
<div><div class="two-column-analysis-style-content-left">254c&ndash;16.</div><div class="two-column-analysis-style-content-right">Mental health services delivered via telehealth.</div></div>
<div><div class="two-column-analysis-style-content-left">254c&ndash;17.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">254c&ndash;18.</div><div class="two-column-analysis-style-content-right">Telemedicine; incentive grants regarding coordination among States.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart ii&mdash;national health service corps program</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">254d.</div><div class="two-column-analysis-style-content-right">National Health Service Corps.</div></div>
<div><div class="two-column-analysis-style-content-left">254e.</div><div class="two-column-analysis-style-content-right">Health professional shortage areas.</div></div>
<div><div class="two-column-analysis-style-content-left">254f.</div><div class="two-column-analysis-style-content-right">Corps personnel.</div></div>
<div><div class="two-column-analysis-style-content-left">254f&ndash;1.</div><div class="two-column-analysis-style-content-right">Priorities in assignment of Corps personnel.</div></div>
<div><div class="two-column-analysis-style-content-left">254g.</div><div class="two-column-analysis-style-content-right">Charges for services by entities using Corps members.</div></div>
<div><div class="two-column-analysis-style-content-left">254h.</div><div class="two-column-analysis-style-content-right">Provision of health services by Corps members.</div></div>
<div><div class="two-column-analysis-style-content-left">254h&ndash;1.</div><div class="two-column-analysis-style-content-right">Facilitation of effective provision of Corps services.</div></div>
<div><div class="two-column-analysis-style-content-left">254i.</div><div class="two-column-analysis-style-content-right">Annual report to Congress; contents.</div></div>
<div><div class="two-column-analysis-style-content-left">254j.</div><div class="two-column-analysis-style-content-right">National Advisory Council on National Health Service Corps.</div></div>
<div><div class="two-column-analysis-style-content-left">254k.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart iii&mdash;scholarship program and loan repayment program</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">254<em>l.</em></div><div class="two-column-analysis-style-content-right">National Health Service Corps Scholarship Program.<!-- PDFPage:17 --></div></div>
<div><div class="two-column-analysis-style-content-left">254<em>l</em>&ndash;1.</div><div class="two-column-analysis-style-content-right">National Health Service Corps Loan Repayment Program.</div></div>
<div><div class="two-column-analysis-style-content-left">254m.</div><div class="two-column-analysis-style-content-right">Obligated service under contract.</div></div>
<div><div class="two-column-analysis-style-content-left">254n.</div><div class="two-column-analysis-style-content-right">Private practice.</div></div>
<div><div class="two-column-analysis-style-content-left">254<em>o.</em></div><div class="two-column-analysis-style-content-right">Breach of scholarship contract or loan repayment contract.</div></div>
<div><div class="two-column-analysis-style-content-left">254<em>o</em>&ndash;1.</div><div class="two-column-analysis-style-content-right">Fund regarding use of amounts recovered for contract breach to replace services lost as result of breach.</div></div>
<div><div class="two-column-analysis-style-content-left">254p.</div><div class="two-column-analysis-style-content-right">Special loans for former Corps members to enter private practice.</div></div>
<div><div class="two-column-analysis-style-content-left">254q.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations.</div></div>
<div><div class="two-column-analysis-style-content-left">254q&ndash;1.</div><div class="two-column-analysis-style-content-right">Grants to States for loan repayment programs.</div></div>
<div><div class="two-column-analysis-style-content-left">254r.</div><div class="two-column-analysis-style-content-right">Grants to States for operation of offices of rural health.</div></div>
<div><div class="two-column-analysis-style-content-left">254s.</div><div class="two-column-analysis-style-content-right">Native Hawaiian Health Scholarships.</div></div>
<div><div class="two-column-analysis-style-content-left">254t.</div><div class="two-column-analysis-style-content-right">Demonstration project.</div></div>
<div><div class="two-column-analysis-style-content-left">254u.</div><div class="two-column-analysis-style-content-right">Public health departments.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart iv&mdash;home health services</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">255.</div><div class="two-column-analysis-style-content-right">Home health services.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart v&mdash;healthy communities access program</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">256.</div><div class="two-column-analysis-style-content-right">Grants to strengthen the effectiveness, efficiency, and coordination of services for the uninsured and underinsured.</div></div>
<div><div class="two-column-analysis-style-content-left">256a.</div><div class="two-column-analysis-style-content-right">Patient navigator grants.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart vii&mdash;drug pricing agreements</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">256b.</div><div class="two-column-analysis-style-content-right">Limitation on prices of drugs purchased by covered entities.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart viii&mdash;bulk purchases of vaccines for certain programs</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">256c.</div><div class="two-column-analysis-style-content-right">Bulk purchases of vaccines for certain programs.</div></div>
<div><div class="two-column-analysis-style-content-left">256d.</div><div class="two-column-analysis-style-content-right">Breast and cervical cancer information.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart ix&mdash;support of graduate medical education programs in children's hospitals</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">256e.</div><div class="two-column-analysis-style-content-right">Program of payments to children's hospitals that operate graduate medical education programs.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart x&mdash;primary dental programs</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">256f.</div><div class="two-column-analysis-style-content-right">Designated dental health professional shortage area.</div></div>
<div><div class="two-column-analysis-style-content-left">256g.</div><div class="two-column-analysis-style-content-right">Grants for innovative programs.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part E&mdash;Narcotic Addicts and Other Drug Abusers</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left" id="wide">257 to 261a. Repealed or Transferred.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part F&mdash;Licensing of Biological Products and Clinical Laboratories</h4>
I74subpart 1&mdash;biological products<div class="analysis">
<div><div class="two-column-analysis-style-content-left">262.</div><div class="two-column-analysis-style-content-right">Regulation of biological products.</div></div>
<div><div class="two-column-analysis-style-content-left">262a.</div><div class="two-column-analysis-style-content-right">Enhanced control of dangerous biological agents and toxins.</div></div>
<div><div class="two-column-analysis-style-content-left">263.</div><div class="two-column-analysis-style-content-right">Preparation of biological products by Service.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 2&mdash;clinical laboratories</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">263a.</div><div class="two-column-analysis-style-content-right">Certification of laboratories.</div></div>
<div><div class="two-column-analysis-style-content-left">263a&ndash;1.</div><div class="two-column-analysis-style-content-right">Assisted reproductive technology programs.</div></div>
<div><div class="two-column-analysis-style-content-left">263a&ndash;2.</div><div class="two-column-analysis-style-content-right">Certification of embryo laboratories.</div></div>
<div><div class="two-column-analysis-style-content-left">263a&ndash;3.</div><div class="two-column-analysis-style-content-right">Accreditation organizations.</div></div>
<div><div class="two-column-analysis-style-content-left">263a&ndash;4.</div><div class="two-column-analysis-style-content-right">Certification revocation and suspension.</div></div>
<div><div class="two-column-analysis-style-content-left">263a&ndash;5.</div><div class="two-column-analysis-style-content-right">Publication.</div></div>
<div><div class="two-column-analysis-style-content-left">263a&ndash;6.</div><div class="two-column-analysis-style-content-right">Fees.</div></div>
<div><div class="two-column-analysis-style-content-left">263a&ndash;7.</div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 3&mdash;mammography facilities</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">263b.</div><div class="two-column-analysis-style-content-right">Certification of mammography facilities.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part G&mdash;Quarantine and Inspection</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">264.</div><div class="two-column-analysis-style-content-right">Regulations to control communicable diseases.</div></div>
<div><div class="two-column-analysis-style-content-left">265.</div><div class="two-column-analysis-style-content-right">Suspension of entries and imports from designated places to prevent spread of communicable diseases.</div></div>
<div><div class="two-column-analysis-style-content-left">266.</div><div class="two-column-analysis-style-content-right">Special quarantine powers in time of war.</div></div>
<div><div class="two-column-analysis-style-content-left">267.</div><div class="two-column-analysis-style-content-right">Quarantine stations, grounds, and anchorages.</div></div>
<div><div class="two-column-analysis-style-content-left">268.</div><div class="two-column-analysis-style-content-right">Quarantine duties of consular and other officers.</div></div>
<div><div class="two-column-analysis-style-content-left">269.</div><div class="two-column-analysis-style-content-right">Bills of health.</div></div>
<div><div class="two-column-analysis-style-content-left">270.</div><div class="two-column-analysis-style-content-right">Quarantine regulations governing civil air navigation and civil aircraft.</div></div>
<div><div class="two-column-analysis-style-content-left">271.</div><div class="two-column-analysis-style-content-right">Penalties for violation of quarantine laws.</div></div>
<div><div class="two-column-analysis-style-content-left">272.</div><div class="two-column-analysis-style-content-right">Administration of oaths by quarantine officers.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part H&mdash;Organ Transplants</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">273.</div><div class="two-column-analysis-style-content-right">Organ procurement organizations.</div></div>
<div><div class="two-column-analysis-style-content-left">273a.</div><div class="two-column-analysis-style-content-right">National living donor mechanisms.</div></div>
<div><div class="two-column-analysis-style-content-left">273b.</div><div class="two-column-analysis-style-content-right">Report on the long-term health effects of living organ donation.</div></div>
<div><div class="two-column-analysis-style-content-left">274.</div><div class="two-column-analysis-style-content-right">Organ procurement and transplantation network.</div></div>
<div><div class="two-column-analysis-style-content-left">274a.</div><div class="two-column-analysis-style-content-right">Scientific registry.</div></div>
<div><div class="two-column-analysis-style-content-left">274b.</div><div class="two-column-analysis-style-content-right">General provisions respecting grants and contracts.</div></div>
<div><div class="two-column-analysis-style-content-left">274c.</div><div class="two-column-analysis-style-content-right">Administration.</div></div>
<div><div class="two-column-analysis-style-content-left">274d.</div><div class="two-column-analysis-style-content-right">Report.</div></div>
<div><div class="two-column-analysis-style-content-left">274e.</div><div class="two-column-analysis-style-content-right">Prohibition of organ purchases.</div></div>
<div><div class="two-column-analysis-style-content-left">274f.</div><div class="two-column-analysis-style-content-right">Reimbursement of travel and subsistence expenses incurred toward living organ donation.</div></div>
<div><div class="two-column-analysis-style-content-left">274f&ndash;1.</div><div class="two-column-analysis-style-content-right">Public awareness; studies and demonstrations.</div></div>
<div><div class="two-column-analysis-style-content-left">274f&ndash;2.</div><div class="two-column-analysis-style-content-right">Grants regarding hospital organ donation coordinators.</div></div>
<div><div class="two-column-analysis-style-content-left">274f&ndash;3.</div><div class="two-column-analysis-style-content-right">Studies relating to organ donation and the recovery, preservation, and transportation of organs.</div></div>
<div><div class="two-column-analysis-style-content-left">274f&ndash;4.</div><div class="two-column-analysis-style-content-right">Report relating to organ donation and the recovery, preservation, and transportation of organs.</div></div>
<div><div class="two-column-analysis-style-content-left">274g.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part I&mdash;C.W. Bill Young Cell Transplantation Program</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">274k.</div><div class="two-column-analysis-style-content-right">National Program.</div></div>
<div><div class="two-column-analysis-style-content-left">274<em>l</em>.</div><div class="two-column-analysis-style-content-right">Stem cell therapeutic outcomes database.</div></div>
<div><div class="two-column-analysis-style-content-left">274<em>l</em>&ndash;1.</div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
<div><div class="two-column-analysis-style-content-left">274m.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations.</div></div>
<div><div class="two-column-analysis-style-content-left">275 to 280a&ndash;1.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part J&mdash;Prevention and Control of Injuries</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">280b.</div><div class="two-column-analysis-style-content-right">Research.</div></div>
<div><div class="two-column-analysis-style-content-left">280b&ndash;1.</div><div class="two-column-analysis-style-content-right">Prevention and control activities.</div></div>
<div><div class="two-column-analysis-style-content-left">280b&ndash;1a.</div><div class="two-column-analysis-style-content-right">Interpersonal violence within families and among acquaintances.</div></div>
<div><div class="two-column-analysis-style-content-left">280b&ndash;1b.</div><div class="two-column-analysis-style-content-right">Prevention of traumatic brain injury.</div></div>
<div><div class="two-column-analysis-style-content-left">280b&ndash;1c.</div><div class="two-column-analysis-style-content-right">Use of allotments for rape prevention education.</div></div>
<div><div class="two-column-analysis-style-content-left">280b&ndash;1d.</div><div class="two-column-analysis-style-content-right">National program for traumatic brain injury registries.</div></div>
<div><div class="two-column-analysis-style-content-left">280b&ndash;2.</div><div class="two-column-analysis-style-content-right">General provisions.</div></div>
<div><div class="two-column-analysis-style-content-left">280b&ndash;3.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations.</div></div>
<div><div class="two-column-analysis-style-content-left">280b&ndash;4.</div><div class="two-column-analysis-style-content-right">Study conducted by the Centers for Disease Control and Prevention.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part K&mdash;Health Care Services in the Home</h4>
I74subpart i&mdash;grants for demonstration projects<div class="analysis">
<div><div class="two-column-analysis-style-content-left">280c.</div><div class="two-column-analysis-style-content-right">Establishment of program.</div></div>
<div><div class="two-column-analysis-style-content-left">280c&ndash;1.</div><div class="two-column-analysis-style-content-right">Limitation on duration of grant and requirement of matching funds.</div></div>
<div><div class="two-column-analysis-style-content-left">280c&ndash;2.</div><div class="two-column-analysis-style-content-right">General provisions.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart ii&mdash;grants for demonstration projects with respect to alzheimer's disease</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">280c&ndash;3.</div><div class="two-column-analysis-style-content-right">Establishment of program.<!-- PDFPage:18 --></div></div>
<div><div class="two-column-analysis-style-content-left">280c&ndash;4.</div><div class="two-column-analysis-style-content-right">Requirement of matching funds.</div></div>
<div><div class="two-column-analysis-style-content-left">280c&ndash;5.</div><div class="two-column-analysis-style-content-right">General provisions.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart iii&mdash;grants for home visiting services for at-risk families</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">280c&ndash;6.</div><div class="two-column-analysis-style-content-right">Projects to improve maternal, infant, and child health.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<!-- field-end:miscellaneous-note -->
<!-- field-start:repeal-note -->
<h4 class="note-head">Part L&mdash;[Repealed]</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">280d.</div><div class="two-column-analysis-style-content-right">Transferred.</div></div>
<div><div class="two-column-analysis-style-content-left">280d&ndash;11.</div><div class="two-column-analysis-style-content-right">Transferred.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<!-- field-end:repeal-note -->
<!-- field-start:miscellaneous-note -->
<h4 class="note-head">Part M&mdash;National Program of Cancer Registries</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">280e.</div><div class="two-column-analysis-style-content-right">National program of cancer registries.</div></div>
<div><div class="two-column-analysis-style-content-left">280e&ndash;1.</div><div class="two-column-analysis-style-content-right">Planning grants regarding registries.</div></div>
<div><div class="two-column-analysis-style-content-left">280e&ndash;2.</div><div class="two-column-analysis-style-content-right">Technical assistance in operations of statewide cancer registries.</div></div>
<div><div class="two-column-analysis-style-content-left">280e&ndash;3.</div><div class="two-column-analysis-style-content-right">Study in certain States to determine factors contributing to elevated breast cancer mortality rates.</div></div>
<div><div class="two-column-analysis-style-content-left">280e&ndash;4.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part N&mdash;National Foundation for the Centers for Disease Control and Prevention</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">280e&ndash;11.</div><div class="two-column-analysis-style-content-right">Establishment and duties of Foundation.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part O&mdash;Fetal Alcohol Syndrome Prevention and Services Program</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">280f.</div><div class="two-column-analysis-style-content-right">Establishment of Fetal Alcohol Syndrome prevention and services program.</div></div>
<div><div class="two-column-analysis-style-content-left">280f&ndash;1.</div><div class="two-column-analysis-style-content-right">Eligibility.</div></div>
<div><div class="two-column-analysis-style-content-left">280f&ndash;2.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations.</div></div>
<div><div class="two-column-analysis-style-content-left">280f&ndash;3.</div><div class="two-column-analysis-style-content-right">Sunset provision.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part P&mdash;Additional Programs</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">280g.</div><div class="two-column-analysis-style-content-right">Children's asthma treatment grants program.</div></div>
<div><div class="two-column-analysis-style-content-left">280g&ndash;1.</div><div class="two-column-analysis-style-content-right">Early detection, diagnosis, and treatment regarding hearing loss in infants.</div></div>
<div><div class="two-column-analysis-style-content-left">280g&ndash;2.</div><div class="two-column-analysis-style-content-right">Childhood malignancies.</div></div>
<div><div class="two-column-analysis-style-content-left">280g&ndash;3.</div><div class="two-column-analysis-style-content-right">.Controlled substance monitoring program.</div></div>
<div><div class="two-column-analysis-style-content-left">280g&ndash;4.</div><div class="two-column-analysis-style-content-right">Grants to foster public health responses to domestic violence, dating violence, sexual assault, and stalking.</div></div>
<div><div class="two-column-analysis-style-content-left">280g&ndash;5.</div><div class="two-column-analysis-style-content-right">Public and health care provider education and support services.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part Q&mdash;Programs To Improve the Health of Children</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">280h.</div><div class="two-column-analysis-style-content-right">Grants to promote childhood nutrition and physical activity.</div></div>
<div><div class="two-column-analysis-style-content-left">280h&ndash;1.</div><div class="two-column-analysis-style-content-right">Applied research program.</div></div>
<div><div class="two-column-analysis-style-content-left">280h&ndash;2.</div><div class="two-column-analysis-style-content-right">Education campaign.</div></div>
<div><div class="two-column-analysis-style-content-left">280h&ndash;3.</div><div class="two-column-analysis-style-content-right">Health professional education and training.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part R&mdash;Programs Relating to Autism</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">280i.</div><div class="two-column-analysis-style-content-right">Developmental disabilities surveillance and research program.</div></div>
<div><div class="two-column-analysis-style-content-left">280i&ndash;1.</div><div class="two-column-analysis-style-content-right">Autism education, early detection, and intervention.</div></div>
<div><div class="two-column-analysis-style-content-left">280i&ndash;2.</div><div class="two-column-analysis-style-content-right">Interagency Autism Coordinating Committee.</div></div>
<div><div class="two-column-analysis-style-content-left">280i&ndash;3.</div><div class="two-column-analysis-style-content-right">Report to Congress.</div></div>
<div><div class="two-column-analysis-style-content-left">280i&ndash;4.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="analysis-subhead">SUBCHAPTER III&mdash;NATIONAL RESEARCH INSTITUTES</h4>
<h4 class="note-head">Part A&mdash;National Institutes of Health</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">281.</div><div class="two-column-analysis-style-content-right">Organization of National Institutes of Health.</div></div>
<div><div class="two-column-analysis-style-content-left">282.</div><div class="two-column-analysis-style-content-right">Director of National Institutes of Health.</div></div>
<div><div class="two-column-analysis-style-content-left">282a.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations.</div></div>
<div><div class="two-column-analysis-style-content-left">282b.</div><div class="two-column-analysis-style-content-right">Electronic coding of grants and activities.</div></div>
<div><div class="two-column-analysis-style-content-left">283.</div><div class="two-column-analysis-style-content-right">Biennial reports of Director of NIH.</div></div>
<div><div class="two-column-analysis-style-content-left">283a.</div><div class="two-column-analysis-style-content-right">Annual reporting to increase interagency collaboration and coordination.</div></div>
<div><div class="two-column-analysis-style-content-left">283a&ndash;1.</div><div class="two-column-analysis-style-content-right">Annual reporting to prevent fraud and abuse.</div></div>
<div><div class="two-column-analysis-style-content-left">283a&ndash;2.</div><div class="two-column-analysis-style-content-right">Annual reporting regarding training of graduate students for doctoral degrees.</div></div>
<div><div class="two-column-analysis-style-content-left">283a&ndash;3.</div><div class="two-column-analysis-style-content-right">Establishment of program regarding DES.</div></div>
<div><div class="two-column-analysis-style-content-left">283b.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">283c.</div><div class="two-column-analysis-style-content-right">Office of Behavioral and Social Sciences Research.</div></div>
<div><div class="two-column-analysis-style-content-left">283d.</div><div class="two-column-analysis-style-content-right">Children's Vaccine Initiative.</div></div>
<div><div class="two-column-analysis-style-content-left">283e.</div><div class="two-column-analysis-style-content-right">Plan for use of animals in research.</div></div>
<div><div class="two-column-analysis-style-content-left">283f.</div><div class="two-column-analysis-style-content-right">Requirements regarding surveys of sexual behavior.</div></div>
<div><div class="two-column-analysis-style-content-left">283g.</div><div class="two-column-analysis-style-content-right">Muscular dystrophy; initiative through Director of National Institutes of Health.</div></div>
<div><div class="two-column-analysis-style-content-left">283h.</div><div class="two-column-analysis-style-content-right">Office of Rare Diseases.</div></div>
<div><div class="two-column-analysis-style-content-left">283i.</div><div class="two-column-analysis-style-content-right">Rare disease regional centers of excellence.</div></div>
<div><div class="two-column-analysis-style-content-left">283j.</div><div class="two-column-analysis-style-content-right">Review of centers of excellence.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part B&mdash;General Provisions Respecting National Research Institutes</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">284.</div><div class="two-column-analysis-style-content-right">Directors of national research institutes.</div></div>
<div><div class="two-column-analysis-style-content-left">284a.</div><div class="two-column-analysis-style-content-right">Advisory councils.</div></div>
<div><div class="two-column-analysis-style-content-left">284b.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">284c.</div><div class="two-column-analysis-style-content-right">Certain uses of funds.</div></div>
<div><div class="two-column-analysis-style-content-left">284d.</div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
<div><div class="two-column-analysis-style-content-left">284e.</div><div class="two-column-analysis-style-content-right">Research on osteoporosis, Paget's disease, and related bone disorders.</div></div>
<div><div class="two-column-analysis-style-content-left">284f.</div><div class="two-column-analysis-style-content-right">Parkinson's disease.</div></div>
<div><div class="two-column-analysis-style-content-left">284g.</div><div class="two-column-analysis-style-content-right">Expansion, intensification, and coordination of activities of National Institutes of Health with respect to research on autism spectrum disorder.</div></div>
<div><div class="two-column-analysis-style-content-left">284h.</div><div class="two-column-analysis-style-content-right">Pediatric Research Initiative.</div></div>
<div><div class="two-column-analysis-style-content-left">284i.</div><div class="two-column-analysis-style-content-right">Autoimmune diseases.</div></div>
<div><div class="two-column-analysis-style-content-left">284j.</div><div class="two-column-analysis-style-content-right">Muscular dystrophy research.</div></div>
<div><div class="two-column-analysis-style-content-left">284k.</div><div class="two-column-analysis-style-content-right">Clinical research.</div></div>
<div><div class="two-column-analysis-style-content-left">284<em>l</em>.</div><div class="two-column-analysis-style-content-right">Enhancement awards.</div></div>
<div><div class="two-column-analysis-style-content-left">284m.</div><div class="two-column-analysis-style-content-right">Program for pediatric studies of drugs.</div></div>
<div><div class="two-column-analysis-style-content-left">284n.</div><div class="two-column-analysis-style-content-right">Certain demonstration projects.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part C&mdash;Specific Provisions Respecting National Research Institutes</h4>
I74subpart 1&mdash;national cancer institute<div class="analysis">
<div><div class="two-column-analysis-style-content-left">285.</div><div class="two-column-analysis-style-content-right">Purpose of Institute.</div></div>
<div><div class="two-column-analysis-style-content-left">285a.</div><div class="two-column-analysis-style-content-right">National Cancer Program.</div></div>
<div><div class="two-column-analysis-style-content-left">285a&ndash;1.</div><div class="two-column-analysis-style-content-right">Cancer control programs.</div></div>
<div><div class="two-column-analysis-style-content-left">285a&ndash;2.</div><div class="two-column-analysis-style-content-right">Special authorities of Director.</div></div>
<div><div class="two-column-analysis-style-content-left">285a&ndash;3.</div><div class="two-column-analysis-style-content-right">National cancer research and demonstration centers.</div></div>
<div><div class="two-column-analysis-style-content-left">285a&ndash;4.</div><div class="two-column-analysis-style-content-right">President's Cancer Panel; establishment, membership, etc., functions.</div></div>
<div><div class="two-column-analysis-style-content-left">285a&ndash;5.</div><div class="two-column-analysis-style-content-right">Associate Director for Prevention; appointment; function.</div></div>
<div><div class="two-column-analysis-style-content-left">285a&ndash;6.</div><div class="two-column-analysis-style-content-right">Breast and gynecological cancers.</div></div>
<div><div class="two-column-analysis-style-content-left">285a&ndash;7.</div><div class="two-column-analysis-style-content-right">Prostate cancer.</div></div>
<div><div class="two-column-analysis-style-content-left">285a&ndash;8.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">285a&ndash;9.</div><div class="two-column-analysis-style-content-right">Grants for education, prevention, and early detection of radiogenic cancers and diseases.</div></div>
<div><div class="two-column-analysis-style-content-left">285a&ndash;10.</div><div class="two-column-analysis-style-content-right">Research, information, and education with respect to blood cancer.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 2&mdash;national heart, lung, and blood institute</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">285b.</div><div class="two-column-analysis-style-content-right">Purpose of Institute.</div></div>
<div><div class="two-column-analysis-style-content-left">285b&ndash;1.</div><div class="two-column-analysis-style-content-right">Heart, blood vessel, lung, and blood disease prevention and control programs.</div></div>
<div><div class="two-column-analysis-style-content-left">285b&ndash;2.</div><div class="two-column-analysis-style-content-right">Information and education.</div></div>
<div><div class="two-column-analysis-style-content-left">285b&ndash;3.</div><div class="two-column-analysis-style-content-right">National Heart, Blood Vessel, Lung, and Blood Diseases and Blood Resources Program; administrative provisions.<!-- PDFPage:19 --></div></div>
<div><div class="two-column-analysis-style-content-left">285b&ndash;4.</div><div class="two-column-analysis-style-content-right">National research and demonstration centers.</div></div>
<div><div class="two-column-analysis-style-content-left">285b&ndash;5.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">285b&ndash;6.</div><div class="two-column-analysis-style-content-right">Associate Director for Prevention; appointment; function.</div></div>
<div><div class="two-column-analysis-style-content-left">285b&ndash;7.</div><div class="two-column-analysis-style-content-right">National Center on Sleep Disorders Research.</div></div>
<div><div class="two-column-analysis-style-content-left">285b&ndash;7a.</div><div class="two-column-analysis-style-content-right">Heart attack, stroke, and other cardiovascular diseases in women.</div></div>
<div><div class="two-column-analysis-style-content-left">285b&ndash;7b.</div><div class="two-column-analysis-style-content-right">Coordination of Federal asthma activities.</div></div>
<div><div class="two-column-analysis-style-content-left">285b&ndash;8.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 3&mdash;national institute of diabetes and digestive and kidney diseases</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">285c.</div><div class="two-column-analysis-style-content-right">Purpose of Institute.</div></div>
<div><div class="two-column-analysis-style-content-left">285c&ndash;1.</div><div class="two-column-analysis-style-content-right">Data systems and information clearinghouses.</div></div>
<div><div class="two-column-analysis-style-content-left">285c&ndash;2.</div><div class="two-column-analysis-style-content-right">Division Directors for Diabetes, Endocrinology, and Metabolic Diseases, Digestive Diseases and Nutrition, and Kidney, Urologic, and Hematologic Diseases; functions.</div></div>
<div><div class="two-column-analysis-style-content-left">285c&ndash;3.</div><div class="two-column-analysis-style-content-right">Interagency coordinating committees.</div></div>
<div><div class="two-column-analysis-style-content-left">285c&ndash;4.</div><div class="two-column-analysis-style-content-right">Advisory boards.</div></div>
<div><div class="two-column-analysis-style-content-left">285c&ndash;5.</div><div class="two-column-analysis-style-content-right">Research and training centers; development or expansion.</div></div>
<div><div class="two-column-analysis-style-content-left">285c&ndash;6.</div><div class="two-column-analysis-style-content-right">Advisory council subcommittees.</div></div>
<div><div class="two-column-analysis-style-content-left">285c&ndash;7.</div><div class="two-column-analysis-style-content-right">Biennial report.</div></div>
<div><div class="two-column-analysis-style-content-left">285c&ndash;8.</div><div class="two-column-analysis-style-content-right">Nutritional disorders program.</div></div>
<div><div class="two-column-analysis-style-content-left">285c&ndash;9.</div><div class="two-column-analysis-style-content-right">Juvenile diabetes.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 4&mdash;national institute of arthritis and musculoskeletal and skin diseases</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">285d.</div><div class="two-column-analysis-style-content-right">Purpose of Institute.</div></div>
<div><div class="two-column-analysis-style-content-left">285d&ndash;1.</div><div class="two-column-analysis-style-content-right">National arthritis and musculoskeletal and skin diseases program.</div></div>
<div><div class="two-column-analysis-style-content-left">285d&ndash;2.</div><div class="two-column-analysis-style-content-right">Research and training.</div></div>
<div><div class="two-column-analysis-style-content-left">285d&ndash;3.</div><div class="two-column-analysis-style-content-right">Data system and information clearinghouse.</div></div>
<div><div class="two-column-analysis-style-content-left">285d&ndash;4.</div><div class="two-column-analysis-style-content-right">Interagency coordinating committees.</div></div>
<div><div class="two-column-analysis-style-content-left">285d&ndash;5.</div><div class="two-column-analysis-style-content-right">Arthritis and musculoskeletal diseases demonstration projects.</div></div>
<div><div class="two-column-analysis-style-content-left">285d&ndash;6.</div><div class="two-column-analysis-style-content-right">Multipurpose arthritis and musculoskeletal diseases centers.</div></div>
<div><div class="two-column-analysis-style-content-left">285d&ndash;6a.</div><div class="two-column-analysis-style-content-right">Lupus.</div></div>
<div><div class="two-column-analysis-style-content-left">285d&ndash;7.</div><div class="two-column-analysis-style-content-right">Advisory Board.</div></div>
<div><div class="two-column-analysis-style-content-left">285d&ndash;8.</div><div class="two-column-analysis-style-content-right">Juvenile arthritis and related conditions.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 5&mdash;national institute on aging</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">285e.</div><div class="two-column-analysis-style-content-right">Purpose of Institute.</div></div>
<div><div class="two-column-analysis-style-content-left">285e&ndash;1.</div><div class="two-column-analysis-style-content-right">Special functions.</div></div>
<div><div class="two-column-analysis-style-content-left">285e&ndash;2.</div><div class="two-column-analysis-style-content-right">Alzheimer's Disease centers.</div></div>
<div><div class="two-column-analysis-style-content-left">285e&ndash;3.</div><div class="two-column-analysis-style-content-right">Claude D. Pepper Older Americans Independence Centers.</div></div>
<div><div class="two-column-analysis-style-content-left">285e&ndash;4.</div><div class="two-column-analysis-style-content-right">Awards for leadership and excellence in Alzheimer's disease and related dementias.</div></div>
<div><div class="two-column-analysis-style-content-left">285e&ndash;5.</div><div class="two-column-analysis-style-content-right">Research relevant to appropriate services for individuals with Alzheimer's disease and related dementias and their families.</div></div>
<div><div class="two-column-analysis-style-content-left">285e&ndash;6.</div><div class="two-column-analysis-style-content-right">Dissemination of research results.</div></div>
<div><div class="two-column-analysis-style-content-left">285e&ndash;7.</div><div class="two-column-analysis-style-content-right">Clearinghouse on Alzheimer's Disease.</div></div>
<div><div class="two-column-analysis-style-content-left">285e&ndash;8.</div><div class="two-column-analysis-style-content-right">Dissemination project.</div></div>
<div><div class="two-column-analysis-style-content-left">285e&ndash;9.</div><div class="two-column-analysis-style-content-right">Alzheimer's disease registry.</div></div>
<div><div class="two-column-analysis-style-content-left">285e&ndash;10.</div><div class="two-column-analysis-style-content-right">Aging processes regarding women.</div></div>
<div><div class="two-column-analysis-style-content-left">285e&ndash;10a.</div><div class="two-column-analysis-style-content-right">Alzheimer's clinical research and training awards.</div></div>
<div><div class="two-column-analysis-style-content-left">285e&ndash;11.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 6&mdash;national institute of allergy and infectious diseases</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">285f.</div><div class="two-column-analysis-style-content-right">Purpose of Institute.</div></div>
<div><div class="two-column-analysis-style-content-left">285f&ndash;1.</div><div class="two-column-analysis-style-content-right">Research centers regarding chronic fatigue syndrome.</div></div>
<div><div class="two-column-analysis-style-content-left">285f&ndash;2.</div><div class="two-column-analysis-style-content-right">Research and research training regarding tuberculosis.</div></div>
<div><div class="two-column-analysis-style-content-left">285f&ndash;3.</div><div class="two-column-analysis-style-content-right">Sexually transmitted disease clinical research and training awards.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 7&mdash;eunice kennedy shriver national institute of child health and human development</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">285g.</div><div class="two-column-analysis-style-content-right">Purpose of Institute.</div></div>
<div><div class="two-column-analysis-style-content-left">285g&ndash;1.</div><div class="two-column-analysis-style-content-right">Sudden infant death syndrome research.</div></div>
<div><div class="two-column-analysis-style-content-left">285g&ndash;2.</div><div class="two-column-analysis-style-content-right">Mental retardation research.</div></div>
<div><div class="two-column-analysis-style-content-left">285g&ndash;3.</div><div class="two-column-analysis-style-content-right">Associate Director for Prevention; appointment; function.</div></div>
<div><div class="two-column-analysis-style-content-left">285g&ndash;4.</div><div class="two-column-analysis-style-content-right">National Center for Medical Rehabilitation Research.</div></div>
<div><div class="two-column-analysis-style-content-left">285g&ndash;5.</div><div class="two-column-analysis-style-content-right">Research centers with respect to contraception and infertility.</div></div>
<div><div class="two-column-analysis-style-content-left">285g&ndash;6.</div><div class="two-column-analysis-style-content-right">Program regarding obstetrics and gynecology.</div></div>
<div><div class="two-column-analysis-style-content-left">285g&ndash;7.</div><div class="two-column-analysis-style-content-right">Child health research centers.</div></div>
<div><div class="two-column-analysis-style-content-left">285g&ndash;8.</div><div class="two-column-analysis-style-content-right">Prospective longitudinal study on adolescent health.</div></div>
<div><div class="two-column-analysis-style-content-left">285g&ndash;9.</div><div class="two-column-analysis-style-content-right">Fragile X.</div></div>
<div><div class="two-column-analysis-style-content-left">285g&ndash;10.</div><div class="two-column-analysis-style-content-right">Investment in tomorrow's pediatric researchers.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 8&mdash;national institute of dental research</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">285h.</div><div class="two-column-analysis-style-content-right">Purpose of Institute.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 9&mdash;national eye institute</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">285i.</div><div class="two-column-analysis-style-content-right">Purpose of Institute.</div></div>
<div><div class="two-column-analysis-style-content-left">285i&ndash;1.</div><div class="two-column-analysis-style-content-right">Clinical research on eye care and diabetes.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 10&mdash;national institute of neurological disorders and stroke</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">285j.</div><div class="two-column-analysis-style-content-right">Purpose of Institute.</div></div>
<div><div class="two-column-analysis-style-content-left">285j&ndash;1.</div><div class="two-column-analysis-style-content-right">Spinal cord regeneration research.</div></div>
<div><div class="two-column-analysis-style-content-left">285j&ndash;2.</div><div class="two-column-analysis-style-content-right">Bioengineering research.</div></div>
<div><div class="two-column-analysis-style-content-left">285j&ndash;3.</div><div class="two-column-analysis-style-content-right">Research on multiple sclerosis.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 11&mdash;national institute of general medical sciences</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">285k.</div><div class="two-column-analysis-style-content-right">Purpose of Institute.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 12&mdash;national institute of environmental health sciences</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">285<em>l</em>.</div><div class="two-column-analysis-style-content-right">Purpose of Institute.</div></div>
<div><div class="two-column-analysis-style-content-left">285<em>l</em>&ndash;1.</div><div class="two-column-analysis-style-content-right">Applied Toxicological Research and Testing Program.</div></div>
<div><div class="two-column-analysis-style-content-left">285<em>l</em>&ndash;2.</div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
<div><div class="two-column-analysis-style-content-left">285<em>l</em>&ndash;3.</div><div class="two-column-analysis-style-content-right">Interagency Coordinating Committee on the Validation of Alternative Methods.</div></div>
<div><div class="two-column-analysis-style-content-left">285<em>l</em>&ndash;4.</div><div class="two-column-analysis-style-content-right">Federal agency action.</div></div>
<div><div class="two-column-analysis-style-content-left">285<em>l</em>&ndash;5.</div><div class="two-column-analysis-style-content-right">Application.</div></div>
<div><div class="two-column-analysis-style-content-left">285<em>l</em>&ndash;6.</div><div class="two-column-analysis-style-content-right">Methods of controlling certain insect and vermin populations.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 13&mdash;national institute on deafness and other communication disorders</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">285m.</div><div class="two-column-analysis-style-content-right">Purpose of Institute.</div></div>
<div><div class="two-column-analysis-style-content-left">285m&ndash;1.</div><div class="two-column-analysis-style-content-right">National Deafness and Other Communication Disorders Program.</div></div>
<div><div class="two-column-analysis-style-content-left">285m&ndash;2.</div><div class="two-column-analysis-style-content-right">Data System and Information Clearinghouse.</div></div>
<div><div class="two-column-analysis-style-content-left">285m&ndash;3.</div><div class="two-column-analysis-style-content-right">Multipurpose deafness and other communication disorders center.</div></div>
<div><div class="two-column-analysis-style-content-left">285m&ndash;4.</div><div class="two-column-analysis-style-content-right">National Institute on Deafness and Other Communication Disorders Advisory Board.</div></div>
<div><div class="two-column-analysis-style-content-left">285m&ndash;5.</div><div class="two-column-analysis-style-content-right">Interagency Coordinating Committee.</div></div>
<div><div class="two-column-analysis-style-content-left">285m&ndash;6.</div><div class="two-column-analysis-style-content-right">Limitation on administrative expenses.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 14&mdash;national institute on alcohol abuse and alcoholism</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">285n.</div><div class="two-column-analysis-style-content-right">Purpose of Institute.</div></div>
<div><div class="two-column-analysis-style-content-left">285n&ndash;1.</div><div class="two-column-analysis-style-content-right">Associate Director for Prevention.</div></div>
<div><div class="two-column-analysis-style-content-left">285n&ndash;2.</div><div class="two-column-analysis-style-content-right">National Alcohol Research Centers; mandatory grant for research of effects of alcohol on elderly.<!-- PDFPage:20 --></div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 15&mdash;national institute on drug abuse</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">285<em>o.</em></div><div class="two-column-analysis-style-content-right">Purpose of Institute.</div></div>
<div><div class="two-column-analysis-style-content-left">285<em>o</em>&ndash;1.</div><div class="two-column-analysis-style-content-right">Associate Director for Prevention.</div></div>
<div><div class="two-column-analysis-style-content-left">285<em>o</em>&ndash;2.</div><div class="two-column-analysis-style-content-right">Drug Abuse Research Centers.</div></div>
<div><div class="two-column-analysis-style-content-left">285<em>o</em>&ndash;3.</div><div class="two-column-analysis-style-content-right">Office on AIDS.</div></div>
<div><div class="two-column-analysis-style-content-left">285<em>o</em>&ndash;4.</div><div class="two-column-analysis-style-content-right">Medication Development Program.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 16&mdash;national institute of mental health</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">285p.</div><div class="two-column-analysis-style-content-right">Purpose of Institute.</div></div>
<div><div class="two-column-analysis-style-content-left">285p&ndash;1.</div><div class="two-column-analysis-style-content-right">Associate Director for Prevention.</div></div>
<div><div class="two-column-analysis-style-content-left">285p&ndash;2.</div><div class="two-column-analysis-style-content-right">Office of Rural Mental Health Research.</div></div>
<div><div class="two-column-analysis-style-content-left">285p&ndash;3.</div><div class="two-column-analysis-style-content-right">Office on AIDS.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 17&mdash;national institute of nursing research</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">285q.</div><div class="two-column-analysis-style-content-right">Purpose of Institute.</div></div>
<div><div class="two-column-analysis-style-content-left">285q&ndash;1.</div><div class="two-column-analysis-style-content-right">Specific authorities.</div></div>
<div><div class="two-column-analysis-style-content-left">285q&ndash;2.</div><div class="two-column-analysis-style-content-right">Advisory council.</div></div>
<div><div class="two-column-analysis-style-content-left">285q&ndash;3.</div><div class="two-column-analysis-style-content-right">Biennial report.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 18&mdash;national institute of biomedical imaging and bioengineering</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">285r.</div><div class="two-column-analysis-style-content-right">Purpose of the Institute.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 19&mdash;national human genome research institute</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">285s.</div><div class="two-column-analysis-style-content-right">Purpose of Institute.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part D&mdash;National Library of Medicine</h4>
I74subpart 1&mdash;general provisions<div class="analysis">
<div><div class="two-column-analysis-style-content-left">286.</div><div class="two-column-analysis-style-content-right">National Library of Medicine.</div></div>
<div><div class="two-column-analysis-style-content-left">286a.</div><div class="two-column-analysis-style-content-right">Board of Regents.</div></div>
<div><div class="two-column-analysis-style-content-left">286a&ndash;1.</div><div class="two-column-analysis-style-content-right">Library facilities.</div></div>
<div><div class="two-column-analysis-style-content-left">286a&ndash;2.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 2&mdash;financial assistance</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">286b.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">286b&ndash;1.</div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
<div><div class="two-column-analysis-style-content-left">286b&ndash;2.</div><div class="two-column-analysis-style-content-right">National Medical Libraries Assistance Advisory Board.</div></div>
<div><div class="two-column-analysis-style-content-left">286b&ndash;3.</div><div class="two-column-analysis-style-content-right">Grants for training in medical library sciences.</div></div>
<div><div class="two-column-analysis-style-content-left">286b&ndash;4.</div><div class="two-column-analysis-style-content-right">Assistance for projects in sciences related to health, for research and development in medical library science, and for development of education technologies.</div></div>
<div><div class="two-column-analysis-style-content-left">286b&ndash;5.</div><div class="two-column-analysis-style-content-right">Grants for establishing, expanding, and improving basic resources of medical libraries and related instrumentalities.</div></div>
<div><div class="two-column-analysis-style-content-left">286b&ndash;6.</div><div class="two-column-analysis-style-content-right">Grants and contracts for establishment of regional medical libraries.</div></div>
<div><div class="two-column-analysis-style-content-left">286b&ndash;7.</div><div class="two-column-analysis-style-content-right">Financial support of biomedical scientific publications.</div></div>
<div><div class="two-column-analysis-style-content-left">286b&ndash;8.</div><div class="two-column-analysis-style-content-right">Grant payments, records, and audit.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 3&mdash;national center for biotechnology information</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">286c.</div><div class="two-column-analysis-style-content-right">Purpose, establishment, functions, and funding of National Center for Biotechnology Information.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 4&mdash;national information center on health services research and health care technology</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">286d.</div><div class="two-column-analysis-style-content-right">National Information Center.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part E&mdash;Other Agencies of NIH</h4>
I74subpart 1&mdash;national center for research resources<div class="analysis">
<div><div class="two-column-analysis-style-content-left">287.</div><div class="two-column-analysis-style-content-right">General purpose.</div></div>
<div><div class="two-column-analysis-style-content-left">287a.</div><div class="two-column-analysis-style-content-right">Advisory council.</div></div>
<div><div class="two-column-analysis-style-content-left">287a&ndash;1.</div><div class="two-column-analysis-style-content-right">Biennial report.</div></div>
<div><div class="two-column-analysis-style-content-left">287a&ndash;2.</div><div class="two-column-analysis-style-content-right">Biomedical and behavioral research facilities.</div></div>
<div><div class="two-column-analysis-style-content-left">287a&ndash;3.</div><div class="two-column-analysis-style-content-right">Construction of regional centers for research on primates.</div></div>
<div><div class="two-column-analysis-style-content-left">287a&ndash;3a.</div><div class="two-column-analysis-style-content-right">Sanctuary system for surplus chimpanzees.</div></div>
<div><div class="two-column-analysis-style-content-left">287a&ndash;4.</div><div class="two-column-analysis-style-content-right">General clinical research centers.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 2&mdash;john e. fogarty international center for advanced study in health sciences</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">287b.</div><div class="two-column-analysis-style-content-right">General purpose.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 3&mdash;national center for human genome research</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">287c.</div><div class="two-column-analysis-style-content-right">Transferred.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 4&mdash;office of dietary supplements</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">287c&ndash;11.</div><div class="two-column-analysis-style-content-right">Dietary supplements.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 5&mdash;national center for complementary and alternative medicine</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">287c&ndash;21.</div><div class="two-column-analysis-style-content-right">Purpose of Center.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 6&mdash;national center on minority health and health disparities</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">287c&ndash;31.</div><div class="two-column-analysis-style-content-right">Purpose of Center.</div></div>
<div><div class="two-column-analysis-style-content-left">287c&ndash;32.</div><div class="two-column-analysis-style-content-right">Centers of excellence for research education and training.</div></div>
<div><div class="two-column-analysis-style-content-left">287c&ndash;33.</div><div class="two-column-analysis-style-content-right">Loan repayment program for minority health disparities research.</div></div>
<div><div class="two-column-analysis-style-content-left">287c&ndash;34.</div><div class="two-column-analysis-style-content-right">General provisions regarding the Center.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part F&mdash;Research on Women's Health</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">287d.</div><div class="two-column-analysis-style-content-right">Office of Research on Women's Health.</div></div>
<div><div class="two-column-analysis-style-content-left">287d&ndash;1.</div><div class="two-column-analysis-style-content-right">National data system and clearinghouse on research on women's health.</div></div>
<div><div class="two-column-analysis-style-content-left">287d&ndash;2.</div><div class="two-column-analysis-style-content-right">Biennial report.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part G&mdash;Awards and Training</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">288.</div><div class="two-column-analysis-style-content-right">Ruth L. Kirschstein National Research Service Awards.</div></div>
<div><div class="two-column-analysis-style-content-left">288&ndash;1.</div><div class="two-column-analysis-style-content-right">Loan repayment program for research with respect to acquired immune deficiency syndrome.</div></div>
<div><div class="two-column-analysis-style-content-left">288&ndash;2.</div><div class="two-column-analysis-style-content-right">Loan repayment program for research with respect to contraception and infertility.</div></div>
<div><div class="two-column-analysis-style-content-left">288&ndash;3.</div><div class="two-column-analysis-style-content-right">Loan repayment program for research generally.</div></div>
<div><div class="two-column-analysis-style-content-left">288&ndash;4.</div><div class="two-column-analysis-style-content-right">Undergraduate scholarship program regarding professions needed by National Research Institutes.</div></div>
<div><div class="two-column-analysis-style-content-left">288&ndash;5.</div><div class="two-column-analysis-style-content-right">Loan repayment program regarding clinical researchers from disadvantaged backgrounds.</div></div>
<div><div class="two-column-analysis-style-content-left">288&ndash;5a.</div><div class="two-column-analysis-style-content-right">Loan repayment program regarding clinical researchers.</div></div>
<div><div class="two-column-analysis-style-content-left">288&ndash;6.</div><div class="two-column-analysis-style-content-right">Pediatric research loan repayment program.</div></div>
<div><div class="two-column-analysis-style-content-left">288a.</div><div class="two-column-analysis-style-content-right">Visiting Scientist Awards.</div></div>
<div><div class="two-column-analysis-style-content-left">288b.</div><div class="two-column-analysis-style-content-right">Studies respecting biomedical and behavioral research personnel.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part H&mdash;General Provisions</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">289.</div><div class="two-column-analysis-style-content-right">Institutional review boards; ethics guidance program.</div></div>
<div><div class="two-column-analysis-style-content-left">289a.</div><div class="two-column-analysis-style-content-right">Peer review requirements.</div></div>
<div><div class="two-column-analysis-style-content-left">289a&ndash;1.</div><div class="two-column-analysis-style-content-right">Certain provisions regarding review and approval of proposals for research.</div></div>
<div><div class="two-column-analysis-style-content-left">289a&ndash;2.</div><div class="two-column-analysis-style-content-right">Inclusion of women and minorities in clinical research.</div></div>
<div><div class="two-column-analysis-style-content-left">289b.</div><div class="two-column-analysis-style-content-right">Office of Research Integrity.</div></div>
<div><div class="two-column-analysis-style-content-left">289b&ndash;1.</div><div class="two-column-analysis-style-content-right">Protection against financial conflicts of interest in certain projects of research.</div></div>
<div><div class="two-column-analysis-style-content-left">289c.</div><div class="two-column-analysis-style-content-right">Research on public health emergencies.</div></div>
<div><div class="two-column-analysis-style-content-left">289c&ndash;1.</div><div class="two-column-analysis-style-content-right">Collaborative use of certain health services research funds.</div></div>
<div><div class="two-column-analysis-style-content-left">289d.</div><div class="two-column-analysis-style-content-right">Animals in research.</div></div>
<div><div class="two-column-analysis-style-content-left">289e.</div><div class="two-column-analysis-style-content-right">Use of appropriations.</div></div>
<div><div class="two-column-analysis-style-content-left">289f.</div><div class="two-column-analysis-style-content-right">Gifts and donations; memorials.</div></div>
<div><div class="two-column-analysis-style-content-left">289g.</div><div class="two-column-analysis-style-content-right">Fetal research.<!-- PDFPage:21 --></div></div>
<div><div class="two-column-analysis-style-content-left">289g&ndash;1.</div><div class="two-column-analysis-style-content-right">Research on transplantation of fetal tissue.</div></div>
<div><div class="two-column-analysis-style-content-left">289g&ndash;2.</div><div class="two-column-analysis-style-content-right">Prohibitions regarding human fetal tissue.</div></div>
<div><div class="two-column-analysis-style-content-left">289g&ndash;3.</div><div class="two-column-analysis-style-content-right">Breast implant research.</div></div>
<div><div class="two-column-analysis-style-content-left">289h.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">290.</div><div class="two-column-analysis-style-content-right">National Institutes of Health Management Fund; establishment; advancements; availability; final adjustments of advances.</div></div>
<div><div class="two-column-analysis-style-content-left">290a.</div><div class="two-column-analysis-style-content-right">Victims of fire.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part I&mdash;Foundation for the National Institutes of Health</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">290b.</div><div class="two-column-analysis-style-content-right">Establishment and duties of Foundation.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="analysis-subhead">SUBCHAPTER III&ndash;A&mdash;SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION</h4>
<h4 class="note-head">Part A&mdash;Organization and General Authorities</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">290aa.</div><div class="two-column-analysis-style-content-right">Substance Abuse and Mental Health Services Administration.</div></div>
<div><div class="two-column-analysis-style-content-left">290aa&ndash;1.</div><div class="two-column-analysis-style-content-right">Advisory councils.</div></div>
<div><div class="two-column-analysis-style-content-left">290aa&ndash;2.</div><div class="two-column-analysis-style-content-right" id="wide">Omitted.</div></div>
<div><div class="two-column-analysis-style-content-left">290aa&ndash;2a.</div><div class="two-column-analysis-style-content-right">Report on individuals with co-occurring mental illness and substance abuse disorders.</div></div>
<div><div class="two-column-analysis-style-content-left">290aa&ndash;3.</div><div class="two-column-analysis-style-content-right">Peer review.</div></div>
<div><div class="two-column-analysis-style-content-left">290aa&ndash;3a.</div><div class="two-column-analysis-style-content-right">Transferred.</div></div>
<div><div class="two-column-analysis-style-content-left">290aa&ndash;4.</div><div class="two-column-analysis-style-content-right">Data collection.</div></div>
<div><div class="two-column-analysis-style-content-left">290aa&ndash;5.</div><div class="two-column-analysis-style-content-right">Grants for the benefit of homeless individuals.</div></div>
<div><div class="two-column-analysis-style-content-left">290aa&ndash;5a.</div><div class="two-column-analysis-style-content-right">Alcohol and drug prevention or treatment services for Indians and Native Alaskans.</div></div>
<div><div class="two-column-analysis-style-content-left">290aa&ndash;5b.</div><div class="two-column-analysis-style-content-right">Grants for ecstasy and other club drugs abuse prevention.</div></div>
<div><div class="two-column-analysis-style-content-left" id="wide">290aa&ndash;6 to 290aa&ndash;14. Transferred or Repealed.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part B&mdash;Centers and Programs</h4>
I74subpart 1&mdash;center for substance abuse treatment<div class="analysis">
<div><div class="two-column-analysis-style-content-left">290bb.</div><div class="two-column-analysis-style-content-right">Center for Substance Abuse Treatment.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;1.</div><div class="two-column-analysis-style-content-right">Residential treatment programs for pregnant and postpartum women.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;1a.</div><div class="two-column-analysis-style-content-right">Transferred.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;2.</div><div class="two-column-analysis-style-content-right">Priority substance abuse treatment needs of regional and national significance.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;2a.</div><div class="two-column-analysis-style-content-right">Medical treatment of narcotics addiction; report to Congress.</div></div>
<div><div class="two-column-analysis-style-content-left" id="wide">290bb&ndash;3 to 290bb&ndash;5. Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;6.</div><div class="two-column-analysis-style-content-right">Action by Center for Substance Abuse Treatment and States concerning military facilities.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;7.</div><div class="two-column-analysis-style-content-right">Substance abuse treatment services for children and adolescents.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;8.</div><div class="two-column-analysis-style-content-right">Early intervention services for children and adolescents.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;9.</div><div class="two-column-analysis-style-content-right">Methamphetamine and amphetamine treatment initiative.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 2&mdash;center for substance abuse prevention</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">290bb&ndash;21.</div><div class="two-column-analysis-style-content-right">Office for Substance Abuse Prevention.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;22.</div><div class="two-column-analysis-style-content-right">Priority substance abuse prevention needs of regional and national significance.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;23.</div><div class="two-column-analysis-style-content-right">Prevention, treatment, and rehabilitation model projects for high risk youth.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;24.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;25.</div><div class="two-column-analysis-style-content-right">Grants for services for children of substance abusers.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;25a.</div><div class="two-column-analysis-style-content-right">Grants for strengthening families.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;25b.</div><div class="two-column-analysis-style-content-right">Programs to reduce underage drinking.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;25c.</div><div class="two-column-analysis-style-content-right">Services for individuals with fetal alcohol syndrome.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;25d.</div><div class="two-column-analysis-style-content-right">Centers of excellence on services for individuals with fetal alcohol syndrome and alcohol-related birth defects and treatment for individuals with such conditions and their families.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;25e.</div><div class="two-column-analysis-style-content-right">Prevention of methamphetamine and inhalant abuse and addiction.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;25f.</div><div class="two-column-analysis-style-content-right">Prevention and education programs.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 3&mdash;center for mental health services</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">290bb&ndash;31.</div><div class="two-column-analysis-style-content-right">Center for Mental Health Services.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;32.</div><div class="two-column-analysis-style-content-right">Priority mental health needs of regional and national significance.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;33.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;34.</div><div class="two-column-analysis-style-content-right">Youth interagency research, training, and technical assistance centers.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;35.</div><div class="two-column-analysis-style-content-right">Services for youth offenders.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;36.</div><div class="two-column-analysis-style-content-right">Youth suicide early intervention and prevention strategies.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;36a.</div><div class="two-column-analysis-style-content-right">Suicide prevention for youth.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;36b.</div><div class="two-column-analysis-style-content-right">Mental and behavioral health services on campus.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;37.</div><div class="two-column-analysis-style-content-right">Grants for emergency mental health centers.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;38.</div><div class="two-column-analysis-style-content-right">Grants for jail diversion programs.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;39.</div><div class="two-column-analysis-style-content-right">Improving outcomes for children and adolescents through services integration between child welfare and mental health services.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;40.</div><div class="two-column-analysis-style-content-right">Grants for the integrated treatment of serious mental illness and co-occurring substance abuse.</div></div>
<div><div class="two-column-analysis-style-content-left">290bb&ndash;41.</div><div class="two-column-analysis-style-content-right">Training grants.</div></div>
<div><div class="two-column-analysis-style-content-left" id="wide">290cc to 290cc&ndash;13. Repealed or Transferred.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part C&mdash;Projects for Assistance in Transition From Homelessness</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">290cc&ndash;21.</div><div class="two-column-analysis-style-content-right">Formula grants to States.</div></div>
<div><div class="two-column-analysis-style-content-left">290cc&ndash;22.</div><div class="two-column-analysis-style-content-right">Purpose of grants.</div></div>
<div><div class="two-column-analysis-style-content-left">290cc&ndash;23.</div><div class="two-column-analysis-style-content-right">Requirement of matching funds.</div></div>
<div><div class="two-column-analysis-style-content-left">290cc&ndash;24.</div><div class="two-column-analysis-style-content-right">Determination of amount of allotment.</div></div>
<div><div class="two-column-analysis-style-content-left">290cc&ndash;25.</div><div class="two-column-analysis-style-content-right">Conversion to categorical program in event of failure of State regarding expenditure of grants.</div></div>
<div><div class="two-column-analysis-style-content-left">290cc&ndash;26.</div><div class="two-column-analysis-style-content-right">Provision of certain information from State.</div></div>
<div><div class="two-column-analysis-style-content-left">290cc&ndash;27.</div><div class="two-column-analysis-style-content-right">Description of intended expenditures of grant.</div></div>
<div><div class="two-column-analysis-style-content-left">290cc&ndash;28.</div><div class="two-column-analysis-style-content-right">Requirement of reports by States.</div></div>
<div><div class="two-column-analysis-style-content-left">290cc&ndash;29.</div><div class="two-column-analysis-style-content-right">Requirement of application.</div></div>
<div><div class="two-column-analysis-style-content-left">290cc&ndash;30.</div><div class="two-column-analysis-style-content-right">Technical assistance.</div></div>
<div><div class="two-column-analysis-style-content-left">290cc&ndash;31.</div><div class="two-column-analysis-style-content-right">Failure to comply with agreements.</div></div>
<div><div class="two-column-analysis-style-content-left">290cc&ndash;32.</div><div class="two-column-analysis-style-content-right">Prohibition against certain false statements.</div></div>
<div><div class="two-column-analysis-style-content-left">290cc&ndash;33.</div><div class="two-column-analysis-style-content-right">Nondiscrimination.</div></div>
<div><div class="two-column-analysis-style-content-left">290cc&ndash;34.</div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
<div><div class="two-column-analysis-style-content-left">290cc&ndash;35.</div><div class="two-column-analysis-style-content-right">Funding.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part D&mdash;Miscellaneous Provisions Relating to Substance Abuse and Mental Health</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">290dd.</div><div class="two-column-analysis-style-content-right">Substance abuse among government and other employees.</div></div>
<div><div class="two-column-analysis-style-content-left">290dd&ndash;1.</div><div class="two-column-analysis-style-content-right">Admission of substance abusers to private and public hospitals and outpatient facilities.</div></div>
<div><div class="two-column-analysis-style-content-left">290dd&ndash;2.</div><div class="two-column-analysis-style-content-right">Confidentiality of records.</div></div>
<div><div class="two-column-analysis-style-content-left" id="wide">290dd&ndash;3 to 290ee&ndash;3. Omitted.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part E&mdash;Children With Serious Emotional Disturbances</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">290ff.</div><div class="two-column-analysis-style-content-right">Comprehensive community mental health services for children with serious emotional disturbances.</div></div>
<div><div class="two-column-analysis-style-content-left">290ff&ndash;1.</div><div class="two-column-analysis-style-content-right">Requirements with respect to carrying out purpose of grants.</div></div>
<div><div class="two-column-analysis-style-content-left">290ff&ndash;2.</div><div class="two-column-analysis-style-content-right">Individualized plan for services.</div></div>
<div><div class="two-column-analysis-style-content-left">290ff&ndash;3.</div><div class="two-column-analysis-style-content-right">Additional provisions.</div></div>
<div><div class="two-column-analysis-style-content-left">290ff&ndash;4.</div><div class="two-column-analysis-style-content-right">General provisions.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part F&mdash;Model Comprehensive Program for Treatment of Substance Abuse</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">290gg.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part G&mdash;Projects for Children and Violence</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">290hh.</div><div class="two-column-analysis-style-content-right">Children and violence.<!-- PDFPage:22 --></div></div>
<div><div class="two-column-analysis-style-content-left">290hh&ndash;1.</div><div class="two-column-analysis-style-content-right">Grants to address the problems of persons who experience violence related stress.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part H&mdash;Requirement Relating to the Rights of Residents of Certain Facilities</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">290ii.</div><div class="two-column-analysis-style-content-right">Requirement relating to the rights of residents of certain facilities.</div></div>
<div><div class="two-column-analysis-style-content-left">290ii&ndash;1.</div><div class="two-column-analysis-style-content-right">Reporting requirement.</div></div>
<div><div class="two-column-analysis-style-content-left">290ii&ndash;2.</div><div class="two-column-analysis-style-content-right">Regulations and enforcement.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part I&mdash;Requirement Relating to the Rights of Residents of Certain Non-Medical, Community-Based Facilities for Children and Youth</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">290jj.</div><div class="two-column-analysis-style-content-right">Requirement relating to the rights of residents of certain non-medical, community-based facilities for children and youth.</div></div>
<div><div class="two-column-analysis-style-content-left">290jj&ndash;1.</div><div class="two-column-analysis-style-content-right">Reporting requirement.</div></div>
<div><div class="two-column-analysis-style-content-left">290jj&ndash;2.</div><div class="two-column-analysis-style-content-right">Regulations and enforcement.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part J&mdash;Services Provided Through Religious Organizations</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">290kk.</div><div class="two-column-analysis-style-content-right">Applicability to designated programs.</div></div>
<div><div class="two-column-analysis-style-content-left">290kk&ndash;1.</div><div class="two-column-analysis-style-content-right">Religious organizations as program participants.</div></div>
<div><div class="two-column-analysis-style-content-left">290kk&ndash;2.</div><div class="two-column-analysis-style-content-right">Limitations on use of funds for certain purposes.</div></div>
<div><div class="two-column-analysis-style-content-left">290kk&ndash;3.</div><div class="two-column-analysis-style-content-right">Educational requirements for personnel in drug treatment programs.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="analysis-subhead">SUBCHAPTER IV&mdash;CONSTRUCTION AND MODERNIZATION OF HOSPITALS AND OTHER MEDICAL FACILITIES</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">291.</div><div class="two-column-analysis-style-content-right">Congressional declaration of purpose.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<!-- field-end:miscellaneous-note -->
<!-- field-start:construction-note -->
<h4 class="note-head">Part A&mdash;Grants and Loans for Construction and Modernization of Hospitals and Other Medical Facilities</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">291a.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations.</div></div>
<div><div class="two-column-analysis-style-content-left">291b.</div><div class="two-column-analysis-style-content-right">State allotments.</div></div>
<div><div class="two-column-analysis-style-content-left">291c.</div><div class="two-column-analysis-style-content-right">General regulations.</div></div>
<div><div class="two-column-analysis-style-content-left">291d.</div><div class="two-column-analysis-style-content-right">State plans.</div></div>
<div><div class="two-column-analysis-style-content-left">291e.</div><div class="two-column-analysis-style-content-right">Projects for construction or modernization.</div></div>
<div><div class="two-column-analysis-style-content-left">291f.</div><div class="two-column-analysis-style-content-right">Payments for construction or modernization.</div></div>
<div><div class="two-column-analysis-style-content-left">291g.</div><div class="two-column-analysis-style-content-right">Withholding of payments; noncompliance with requirements.</div></div>
<div><div class="two-column-analysis-style-content-left">291h.</div><div class="two-column-analysis-style-content-right">Judicial review.</div></div>
<div><div class="two-column-analysis-style-content-left">291i.</div><div class="two-column-analysis-style-content-right">Recovery of expenditures under certain conditions.</div></div>
<div><div class="two-column-analysis-style-content-left">291j.</div><div class="two-column-analysis-style-content-right">Loans.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part B&mdash;Loan Guarantees and Loans for Modernization and Construction of Hospitals and Other Medical Facilities</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">291j&ndash;1.</div><div class="two-column-analysis-style-content-right">Loan guarantees and loans.</div></div>
<div><div class="two-column-analysis-style-content-left">291j&ndash;2.</div><div class="two-column-analysis-style-content-right">Allocation among States.</div></div>
<div><div class="two-column-analysis-style-content-left">291j&ndash;3.</div><div class="two-column-analysis-style-content-right">Applications and conditions.</div></div>
<div><div class="two-column-analysis-style-content-left">291j&ndash;4.</div><div class="two-column-analysis-style-content-right">Payment of interest on guaranteed loans.</div></div>
<div><div class="two-column-analysis-style-content-left">291j&ndash;5.</div><div class="two-column-analysis-style-content-right">Limitation on amounts of loans guaranteed or directly made.</div></div>
<div><div class="two-column-analysis-style-content-left">291j&ndash;6.</div><div class="two-column-analysis-style-content-right">Loan guarantee and loan fund.</div></div>
<div><div class="two-column-analysis-style-content-left">291j&ndash;7.</div><div class="two-column-analysis-style-content-right">Loans to public facilities.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part C&mdash;Construction or Modernization of Emergency Rooms</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">291j&ndash;8.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations.</div></div>
<div><div class="two-column-analysis-style-content-left">291j&ndash;9.</div><div class="two-column-analysis-style-content-right">Eligibility for grants.</div></div>
<div><div class="two-column-analysis-style-content-left">291j&ndash;10.</div><div class="two-column-analysis-style-content-right">Payments.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<!-- field-end:construction-note -->
<!-- field-start:miscellaneous-note -->
<h4 class="note-head">Part D&mdash;General Provisions</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">291k.</div><div class="two-column-analysis-style-content-right">Federal Hospital Council.</div></div>
<div><div class="two-column-analysis-style-content-left">291<em>l.</em></div><div class="two-column-analysis-style-content-right">Conference of State agencies.</div></div>
<div><div class="two-column-analysis-style-content-left">291m.</div><div class="two-column-analysis-style-content-right">State control of operations.</div></div>
<div><div class="two-column-analysis-style-content-left">291m&ndash;1.</div><div class="two-column-analysis-style-content-right">Loans for certain hospital experimentation projects.</div></div>
<div><div class="two-column-analysis-style-content-left">291n, 291n&ndash;1.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed or Omitted.</div></div>
<div><div class="two-column-analysis-style-content-left">291<em>o.</em></div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
<div><div class="two-column-analysis-style-content-left">291<em>o</em>&ndash;1.</div><div class="two-column-analysis-style-content-right">Financial statements.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="analysis-subhead">SUBCHAPTER V&mdash;HEALTH PROFESSIONS EDUCATION</h4>
<h4 class="note-head">Part A&mdash;Student Loans</h4>
I74subpart i&ndash;insured health education assistance loans to graduate students<div class="analysis">
<div><div class="two-column-analysis-style-content-left">292.</div><div class="two-column-analysis-style-content-right">Statement of purpose.</div></div>
<div><div class="two-column-analysis-style-content-left">292a.</div><div class="two-column-analysis-style-content-right">Scope and duration of loan insurance program.</div></div>
<div><div class="two-column-analysis-style-content-left">292b.</div><div class="two-column-analysis-style-content-right">Limitations on individual insured loans and on loan insurance.</div></div>
<div><div class="two-column-analysis-style-content-left">292c.</div><div class="two-column-analysis-style-content-right">Sources of funds.</div></div>
<div><div class="two-column-analysis-style-content-left">292d.</div><div class="two-column-analysis-style-content-right">Eligibility of borrowers and terms of insured loans.</div></div>
<div><div class="two-column-analysis-style-content-left">292e.</div><div class="two-column-analysis-style-content-right">Certificate of loan insurance; effective date of insurance.</div></div>
<div><div class="two-column-analysis-style-content-left">292f.</div><div class="two-column-analysis-style-content-right">Default of borrower.</div></div>
<div><div class="two-column-analysis-style-content-left">292g.</div><div class="two-column-analysis-style-content-right">Risk-based premiums.</div></div>
<div><div class="two-column-analysis-style-content-left">292h.</div><div class="two-column-analysis-style-content-right">Office for Health Education Assistance Loan Default Reduction.</div></div>
<div><div class="two-column-analysis-style-content-left">292i.</div><div class="two-column-analysis-style-content-right">Insurance account.</div></div>
<div><div class="two-column-analysis-style-content-left">292j.</div><div class="two-column-analysis-style-content-right">Powers and responsibilities of Secretary.</div></div>
<div><div class="two-column-analysis-style-content-left">292k.</div><div class="two-column-analysis-style-content-right">Participation by Federal credit unions in Federal, State, and private student loan insurance programs.</div></div>
<div><div class="two-column-analysis-style-content-left">292<em>l.</em></div><div class="two-column-analysis-style-content-right">Determination of eligible students.</div></div>
<div><div class="two-column-analysis-style-content-left">292m.</div><div class="two-column-analysis-style-content-right">Repayment by Secretary of loans of deceased or disabled borrowers.</div></div>
<div><div class="two-column-analysis-style-content-left">292n.</div><div class="two-column-analysis-style-content-right">Additional requirements for institutions and lenders.</div></div>
<div><div class="two-column-analysis-style-content-left">292<em>o.</em></div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
<div><div class="two-column-analysis-style-content-left">292p.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart ii&mdash;federally-supported student loan funds</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">292q.</div><div class="two-column-analysis-style-content-right">Agreements for operation of school loan funds.</div></div>
<div><div class="two-column-analysis-style-content-left">292r.</div><div class="two-column-analysis-style-content-right">Loan provisions.</div></div>
<div><div class="two-column-analysis-style-content-left">292s.</div><div class="two-column-analysis-style-content-right">Medical schools and primary health care.</div></div>
<div><div class="two-column-analysis-style-content-left">292t.</div><div class="two-column-analysis-style-content-right">Individuals from disadvantaged backgrounds.</div></div>
<div><div class="two-column-analysis-style-content-left">292u.</div><div class="two-column-analysis-style-content-right">Administrative provisions.</div></div>
<div><div class="two-column-analysis-style-content-left">292v.</div><div class="two-column-analysis-style-content-right">Provision by schools of information to students.</div></div>
<div><div class="two-column-analysis-style-content-left">292w.</div><div class="two-column-analysis-style-content-right">Procedures for appeal of termination of agreements.</div></div>
<div><div class="two-column-analysis-style-content-left">292x.</div><div class="two-column-analysis-style-content-right">Distribution of assets from loan funds.</div></div>
<div><div class="two-column-analysis-style-content-left">292y.</div><div class="two-column-analysis-style-content-right">General provisions.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part B&mdash;Health Professions Training for Diversity</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">293.</div><div class="two-column-analysis-style-content-right">Centers of excellence.</div></div>
<div><div class="two-column-analysis-style-content-left">293a.</div><div class="two-column-analysis-style-content-right">Scholarships for disadvantaged students.</div></div>
<div><div class="two-column-analysis-style-content-left">293b.</div><div class="two-column-analysis-style-content-right">Loan repayments and fellowships regarding faculty positions.</div></div>
<div><div class="two-column-analysis-style-content-left">293c.</div><div class="two-column-analysis-style-content-right">Educational assistance in the health professions regarding individuals from disadvantaged backgrounds.</div></div>
<div><div class="two-column-analysis-style-content-left">293d.</div><div class="two-column-analysis-style-content-right">Authorization of appropriation.</div></div>
<div><div class="two-column-analysis-style-content-left">293e.</div><div class="two-column-analysis-style-content-right">Grants for health professions education.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part C&mdash;Training in Family Medicine, General Internal Medicine, General Pediatrics, Physician Assistants, General Dentistry, and Pediatric Dentistry</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">293j.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">293k.</div><div class="two-column-analysis-style-content-right">Family medicine, general internal medicine, general pediatrics, general dentistry, pediatric dentistry, and physician assistants.</div></div>
<div><div class="two-column-analysis-style-content-left">293<em>l</em>.</div><div class="two-column-analysis-style-content-right">Advisory Committee on Training in Primary Care Medicine and Dentistry.<!-- PDFPage:23 --></div></div>
<div><div class="two-column-analysis-style-content-left">293m to 293p.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part D&mdash;Interdisciplinary, Community-Based Linkages</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">294.</div><div class="two-column-analysis-style-content-right">General provisions.</div></div>
<div><div class="two-column-analysis-style-content-left">294a.</div><div class="two-column-analysis-style-content-right">Area health education centers.</div></div>
<div><div class="two-column-analysis-style-content-left">294b.</div><div class="two-column-analysis-style-content-right">Health education and training centers.</div></div>
<div><div class="two-column-analysis-style-content-left">294c.</div><div class="two-column-analysis-style-content-right">Education and training relating to geriatrics.</div></div>
<div><div class="two-column-analysis-style-content-left">294d.</div><div class="two-column-analysis-style-content-right">Quentin N. Burdick program for rural interdisciplinary training.</div></div>
<div><div class="two-column-analysis-style-content-left">294e.</div><div class="two-column-analysis-style-content-right">Allied health and other disciplines.</div></div>
<div><div class="two-column-analysis-style-content-left">294f.</div><div class="two-column-analysis-style-content-right">Advisory Committee on Interdisciplinary, Community-Based Linkages.</div></div>
<div><div class="two-column-analysis-style-content-left">294g.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations.</div></div>
<div><div class="two-column-analysis-style-content-left">294h.</div><div class="two-column-analysis-style-content-right">Interdisciplinary training and education on domestic violence and other types of violence and abuse.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part E&mdash;Health Professions and Public Health Workforce</h4>
I74subpart 1&mdash;health professions workforce information and analysis<div class="analysis">
<div><div class="two-column-analysis-style-content-left">294n.</div><div class="two-column-analysis-style-content-right">Health professions workforce information and analysis.</div></div>
<div><div class="two-column-analysis-style-content-left">294<em>o</em>.</div><div class="two-column-analysis-style-content-right">Advisory Council on Graduate Medical Education.</div></div>
<div><div class="two-column-analysis-style-content-left">294p.</div><div class="two-column-analysis-style-content-right">Pediatric rheumatology.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 2&mdash;public health workforce</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">295.</div><div class="two-column-analysis-style-content-right">General provisions.</div></div>
<div><div class="two-column-analysis-style-content-left">295a.</div><div class="two-column-analysis-style-content-right">Public health training centers.</div></div>
<div><div class="two-column-analysis-style-content-left">295b.</div><div class="two-column-analysis-style-content-right">Public health traineeships.</div></div>
<div><div class="two-column-analysis-style-content-left">295c.</div><div class="two-column-analysis-style-content-right">Preventive medicine; dental public health.</div></div>
<div><div class="two-column-analysis-style-content-left">295d.</div><div class="two-column-analysis-style-content-right">Health administration traineeships and special projects.</div></div>
<div><div class="two-column-analysis-style-content-left">295e.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part F&mdash;General Provisions</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">295j.</div><div class="two-column-analysis-style-content-right">Preferences and required information in certain programs.</div></div>
<div><div class="two-column-analysis-style-content-left">295k.</div><div class="two-column-analysis-style-content-right">Health professions data.</div></div>
<div><div class="two-column-analysis-style-content-left">295<em>l.</em></div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">295m.</div><div class="two-column-analysis-style-content-right">Prohibition against discrimination on basis of sex.</div></div>
<div><div class="two-column-analysis-style-content-left">295n.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">295n&ndash;1.</div><div class="two-column-analysis-style-content-right">Application.</div></div>
<div><div class="two-column-analysis-style-content-left">295n&ndash;2.</div><div class="two-column-analysis-style-content-right">Use of funds.</div></div>
<div><div class="two-column-analysis-style-content-left">295<em>o</em>.</div><div class="two-column-analysis-style-content-right">Matching requirement.</div></div>
<div><div class="two-column-analysis-style-content-left">295<em>o</em>&ndash;1.</div><div class="two-column-analysis-style-content-right">Generally applicable provisions.</div></div>
<div><div class="two-column-analysis-style-content-left">295<em>o</em>&ndash;2.</div><div class="two-column-analysis-style-content-right">Technical assistance.</div></div>
<div><div class="two-column-analysis-style-content-left">295p.</div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="analysis-subhead">SUBCHAPTER VI&mdash;NURSING WORKFORCE DEVELOPMENT</h4>
<h4 class="note-head">Part A&mdash;General Provisions</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">296.</div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
<div><div class="two-column-analysis-style-content-left">296a.</div><div class="two-column-analysis-style-content-right">Application.</div></div>
<div><div class="two-column-analysis-style-content-left">296b.</div><div class="two-column-analysis-style-content-right">Use of funds.</div></div>
<div><div class="two-column-analysis-style-content-left">296c.</div><div class="two-column-analysis-style-content-right">Matching requirement.</div></div>
<div><div class="two-column-analysis-style-content-left">296d.</div><div class="two-column-analysis-style-content-right">Preference.</div></div>
<div><div class="two-column-analysis-style-content-left">296e.</div><div class="two-column-analysis-style-content-right">Generally applicable provisions.</div></div>
<div><div class="two-column-analysis-style-content-left">296e&ndash;1.</div><div class="two-column-analysis-style-content-right">Grants for health professions education.</div></div>
<div><div class="two-column-analysis-style-content-left">296f.</div><div class="two-column-analysis-style-content-right">Technical assistance.</div></div>
<div><div class="two-column-analysis-style-content-left">296g.</div><div class="two-column-analysis-style-content-right">Prohibition against discrimination by schools on basis of sex.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part B&mdash;Nurse Practitioners, Nurse Midwives, Nurse Anesthetists, and Other Advanced Education Nurses</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">296j.</div><div class="two-column-analysis-style-content-right">Advanced education nursing grants.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part C&mdash;Increasing Nursing Workforce Diversity</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">296m.</div><div class="two-column-analysis-style-content-right">Workforce diversity grants.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part D&mdash;Strengthening Capacity for Basic Nurse Education and Practice</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">296p.</div><div class="two-column-analysis-style-content-right">Nurse education, practice, and retention grants.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part E&mdash;Student Loans</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">297a.</div><div class="two-column-analysis-style-content-right">Student loan fund.</div></div>
<div><div class="two-column-analysis-style-content-left">297b.</div><div class="two-column-analysis-style-content-right">Loan provisions.</div></div>
<div><div class="two-column-analysis-style-content-left">297c, 297c&ndash;1.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">297d.</div><div class="two-column-analysis-style-content-right">Allotments and payments of Federal capital contributions.</div></div>
<div><div class="two-column-analysis-style-content-left">297e.</div><div class="two-column-analysis-style-content-right">Distribution of assets from loan funds.</div></div>
<div><div class="two-column-analysis-style-content-left">297f.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">297g.</div><div class="two-column-analysis-style-content-right">Modification of agreements; compromise, waiver or release.</div></div>
<div><div class="two-column-analysis-style-content-left">297h.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">297i.</div><div class="two-column-analysis-style-content-right">Procedures for appeal of terminations.</div></div>
<div><div class="two-column-analysis-style-content-left">297n.</div><div class="two-column-analysis-style-content-right">Loan repayment and scholarship programs.</div></div>
<div><div class="two-column-analysis-style-content-left">297n&ndash;1.</div><div class="two-column-analysis-style-content-right">Nurse faculty loan program.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part F&mdash;Funding</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">297q.</div><div class="two-column-analysis-style-content-right">Funding.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part G&mdash;National Advisory Council on Nurse Education and Practice</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">297t.</div><div class="two-column-analysis-style-content-right">National Advisory Council on Nurse Education and Practice.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part H&mdash;Public Service Announcements</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">297w.</div><div class="two-column-analysis-style-content-right">Public service announcements.</div></div>
<div><div class="two-column-analysis-style-content-left">297x.</div><div class="two-column-analysis-style-content-right">State and local public service announcements.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part I&mdash;Comprehensive Geriatric Education</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">298.</div><div class="two-column-analysis-style-content-right">Comprehensive geriatric education.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="analysis-subhead">SUBCHAPTER VII&mdash;AGENCY FOR HEALTHCARE RESEARCH AND QUALITY</h4>
<h4 class="note-head">Part A&mdash;Establishment and General Duties</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">299.</div><div class="two-column-analysis-style-content-right">Mission and duties.</div></div>
<div><div class="two-column-analysis-style-content-left">299a.</div><div class="two-column-analysis-style-content-right">General authorities.</div></div>
<div><div class="two-column-analysis-style-content-left">299a&ndash;1.</div><div class="two-column-analysis-style-content-right">Research on health disparities.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part B&mdash;Health Care Improvement Research</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">299b.</div><div class="two-column-analysis-style-content-right">Health care outcome improvement research.</div></div>
<div><div class="two-column-analysis-style-content-left">299b&ndash;1.</div><div class="two-column-analysis-style-content-right">Private-public partnerships to improve organization and delivery.</div></div>
<div><div class="two-column-analysis-style-content-left">299b&ndash;2.</div><div class="two-column-analysis-style-content-right">Information on quality and cost of care.</div></div>
<div><div class="two-column-analysis-style-content-left">299b&ndash;3.</div><div class="two-column-analysis-style-content-right">Information systems for health care improvement.</div></div>
<div><div class="two-column-analysis-style-content-left">299b&ndash;4.</div><div class="two-column-analysis-style-content-right">Research supporting primary care and access in underserved areas.</div></div>
<div><div class="two-column-analysis-style-content-left">299b&ndash;4a.</div><div class="two-column-analysis-style-content-right">Studies on preventive interventions in primary care for older Americans.</div></div>
<div><div class="two-column-analysis-style-content-left">299b&ndash;5.</div><div class="two-column-analysis-style-content-right">Health care practice and technology innovation.</div></div>
<div><div class="two-column-analysis-style-content-left">299b&ndash;6.</div><div class="two-column-analysis-style-content-right">Coordination of Federal Government quality improvement efforts.</div></div>
<div><div class="two-column-analysis-style-content-left">299b&ndash;7.</div><div class="two-column-analysis-style-content-right">Research on outcomes of health care items and services.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part C&mdash;Patient Safety Improvement</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">299b&ndash;21.</div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
<div><div class="two-column-analysis-style-content-left">299b&ndash;22.</div><div class="two-column-analysis-style-content-right">Privilege and confidentiality protections.</div></div>
<div><div class="two-column-analysis-style-content-left">299b&ndash;23.</div><div class="two-column-analysis-style-content-right">Network of patient safety databases.</div></div>
<div><div class="two-column-analysis-style-content-left">299b&ndash;24.</div><div class="two-column-analysis-style-content-right">Patient safety organization certification and listing.</div></div>
<div><div class="two-column-analysis-style-content-left">299b&ndash;25.</div><div class="two-column-analysis-style-content-right">Technical assistance.</div></div>
<div><div class="two-column-analysis-style-content-left">299b&ndash;26.</div><div class="two-column-analysis-style-content-right">Severability.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part D&mdash;General Provisions</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">299c.</div><div class="two-column-analysis-style-content-right">Advisory Council for Healthcare Research and Quality.</div></div>
<div><div class="two-column-analysis-style-content-left">299c&ndash;1.</div><div class="two-column-analysis-style-content-right">Peer review with respect to grants and contracts.</div></div>
<div><div class="two-column-analysis-style-content-left">299c&ndash;2.</div><div class="two-column-analysis-style-content-right">Certain provisions with respect to development, collection, and dissemination of data.<!-- PDFPage:24 --></div></div>
<div><div class="two-column-analysis-style-content-left">299c&ndash;3.</div><div class="two-column-analysis-style-content-right">Dissemination of information.</div></div>
<div><div class="two-column-analysis-style-content-left">299c&ndash;4.</div><div class="two-column-analysis-style-content-right">Additional provisions with respect to grants and contracts.</div></div>
<div><div class="two-column-analysis-style-content-left">299c&ndash;5.</div><div class="two-column-analysis-style-content-right">Certain administrative authorities.</div></div>
<div><div class="two-column-analysis-style-content-left">299c&ndash;6.</div><div class="two-column-analysis-style-content-right">Funding.</div></div>
<div><div class="two-column-analysis-style-content-left">299c&ndash;7.</div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="analysis-subhead">SUBCHAPTER VIII&mdash;POPULATION RESEARCH AND VOLUNTARY FAMILY PLANNING PROGRAMS</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300.</div><div class="two-column-analysis-style-content-right">Project grants and contracts for family planning services.</div></div>
<div><div class="two-column-analysis-style-content-left">300a.</div><div class="two-column-analysis-style-content-right">Formula grants to States for family planning services.</div></div>
<div><div class="two-column-analysis-style-content-left">300a&ndash;1.</div><div class="two-column-analysis-style-content-right">Training grants and contracts; authorization of appropriations.</div></div>
<div><div class="two-column-analysis-style-content-left">300a&ndash;2.</div><div class="two-column-analysis-style-content-right">Conduct, etc., of research activities.</div></div>
<div><div class="two-column-analysis-style-content-left">300a&ndash;3.</div><div class="two-column-analysis-style-content-right">Informational and educational materials development grants and contracts; authorization of appropriations.</div></div>
<div><div class="two-column-analysis-style-content-left">300a&ndash;4.</div><div class="two-column-analysis-style-content-right">Grants and contracts.</div></div>
<div><div class="two-column-analysis-style-content-left">300a&ndash;5.</div><div class="two-column-analysis-style-content-right">Voluntary participation by individuals; participation not prerequisite for eligibility or receipt of other services and information.</div></div>
<div><div class="two-column-analysis-style-content-left">300a&ndash;6.</div><div class="two-column-analysis-style-content-right">Prohibition against funding programs using abortion as family planning method.</div></div>
<div><div class="two-column-analysis-style-content-left">300a&ndash;6a.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">300a&ndash;7.</div><div class="two-column-analysis-style-content-right">Sterilization or abortion.</div></div>
<div><div class="two-column-analysis-style-content-left">300a&ndash;8.</div><div class="two-column-analysis-style-content-right">Penalty for United States, etc., officer or employee coercing or endeavoring to coerce procedure upon beneficiary of Federal program.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="analysis-subhead">SUBCHAPTER VIII&ndash;A&mdash;ADOLESCENT PREGNANCIES</h4>
<h4 class="note-head">Part A&mdash;Grant Program</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left" id="wide">300a&ndash;21 to 300a&ndash;29. Repealed or Omitted.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part B&mdash;Improving Coordination of Federal and State Programs</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300a&ndash;41.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="analysis-subhead">SUBCHAPTER IX&mdash;GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME</h4>
<h4 class="note-head">Part A&mdash;Genetic Diseases</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300b.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">300b&ndash;1.</div><div class="two-column-analysis-style-content-right">Research project grants and contracts.</div></div>
<div><div class="two-column-analysis-style-content-left">300b&ndash;2.</div><div class="two-column-analysis-style-content-right">Voluntary participation by individuals.</div></div>
<div><div class="two-column-analysis-style-content-left">300b&ndash;3.</div><div class="two-column-analysis-style-content-right">Application; special consideration to prior sickle cell anemia grant recipients.</div></div>
<div><div class="two-column-analysis-style-content-left">300b&ndash;4.</div><div class="two-column-analysis-style-content-right">Public Health Service facilities.</div></div>
<div><div class="two-column-analysis-style-content-left">300b&ndash;5.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">300b&ndash;6.</div><div class="two-column-analysis-style-content-right">Applied technology.</div></div>
<div><div class="two-column-analysis-style-content-left">300b&ndash;7.</div><div class="two-column-analysis-style-content-right">Tourette Syndrome.</div></div>
<div><div class="two-column-analysis-style-content-left">300b&ndash;8.</div><div class="two-column-analysis-style-content-right">Improved newborn and child screening for heritable disorders.</div></div>
<div><div class="two-column-analysis-style-content-left">300b&ndash;9.</div><div class="two-column-analysis-style-content-right">Evaluating the effectiveness of newborn and child screening programs.</div></div>
<div><div class="two-column-analysis-style-content-left">300b&ndash;10.</div><div class="two-column-analysis-style-content-right">Advisory Committee on Heritable Disorders in Newborns and Children.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part B&mdash;Sudden Infant Death Syndrome</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300c&ndash;11.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">300c&ndash;12.</div><div class="two-column-analysis-style-content-right">Sudden infant death syndrome research.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part C&mdash;Hemophilia Programs</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300c&ndash;21.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">300c&ndash;22.</div><div class="two-column-analysis-style-content-right">Blood-separation centers.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="analysis-subhead">SUBCHAPTER X&mdash;TRAUMA CARE</h4>
<h4 class="note-head">Part A&mdash;General Authority and Duties of Secretary</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300d.</div><div class="two-column-analysis-style-content-right">Establishment.</div></div>
<div><div class="two-column-analysis-style-content-left">300d&ndash;1, 300d&ndash;2.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">300d&ndash;3.</div><div class="two-column-analysis-style-content-right">Establishment of programs for improving trauma care in rural areas.</div></div>
<div><div class="two-column-analysis-style-content-left">300d&ndash;4.</div><div class="two-column-analysis-style-content-right">Emergency medical services.</div></div>
<div><div class="two-column-analysis-style-content-left">300d&ndash;5.</div><div class="two-column-analysis-style-content-right">Competitive grants for the improvement of trauma care.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part B&mdash;Formula Grants With Respect to Modifications of State Plans</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300d&ndash;11.</div><div class="two-column-analysis-style-content-right">Establishment of program.</div></div>
<div><div class="two-column-analysis-style-content-left">300d&ndash;12.</div><div class="two-column-analysis-style-content-right">Requirement of matching funds for fiscal years subsequent to first fiscal year of payments.</div></div>
<div><div class="two-column-analysis-style-content-left">300d&ndash;13.</div><div class="two-column-analysis-style-content-right">Requirements with respect to carrying out purpose of allotments.</div></div>
<div><div class="two-column-analysis-style-content-left">300d&ndash;14.</div><div class="two-column-analysis-style-content-right">Requirement of submission to Secretary of trauma plan and certain information.</div></div>
<div><div class="two-column-analysis-style-content-left">300d&ndash;15.</div><div class="two-column-analysis-style-content-right">Restrictions on use of payments.</div></div>
<div><div class="two-column-analysis-style-content-left">300d&ndash;16.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">300d&ndash;17.</div><div class="two-column-analysis-style-content-right">Requirement of submission of application containing certain agreements and assurances.</div></div>
<div><div class="two-column-analysis-style-content-left">300d&ndash;18.</div><div class="two-column-analysis-style-content-right">Determination of amount of allotment.</div></div>
<div><div class="two-column-analysis-style-content-left">300d&ndash;19.</div><div class="two-column-analysis-style-content-right">Failure to comply with agreements.</div></div>
<div><div class="two-column-analysis-style-content-left">300d&ndash;20.</div><div class="two-column-analysis-style-content-right">Prohibition against certain false statements.</div></div>
<div><div class="two-column-analysis-style-content-left">300d&ndash;21.</div><div class="two-column-analysis-style-content-right">Technical assistance and provision by Secretary of supplies and services in lieu of grant funds.</div></div>
<div><div class="two-column-analysis-style-content-left">300d&ndash;22.</div><div class="two-column-analysis-style-content-right">Report by Secretary.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part C&mdash;General Provisions Regarding Parts A and B</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300d&ndash;31.</div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
<div><div class="two-column-analysis-style-content-left">300d&ndash;32.</div><div class="two-column-analysis-style-content-right">Funding.</div></div>
<div><div class="two-column-analysis-style-content-left">300d&ndash;33.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part D&mdash;Trauma Centers Operating in Areas Severely Affected by Drug-Related Violence</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300d&ndash;41.</div><div class="two-column-analysis-style-content-right">Grants for certain trauma centers.</div></div>
<div><div class="two-column-analysis-style-content-left">300d&ndash;42.</div><div class="two-column-analysis-style-content-right">Preferences in making grants.</div></div>
<div><div class="two-column-analysis-style-content-left">300d&ndash;43.</div><div class="two-column-analysis-style-content-right">Certain agreements.</div></div>
<div><div class="two-column-analysis-style-content-left">300d&ndash;44.</div><div class="two-column-analysis-style-content-right">General provisions.</div></div>
<div><div class="two-column-analysis-style-content-left">300d&ndash;45.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part E&mdash;Miscellaneous Programs</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300d&ndash;51.</div><div class="two-column-analysis-style-content-right">Residency training programs in emergency medicine.</div></div>
<div><div class="two-column-analysis-style-content-left">300d&ndash;52.</div><div class="two-column-analysis-style-content-right">State grants for projects regarding traumatic brain injury.</div></div>
<div><div class="two-column-analysis-style-content-left">300d&ndash;53.</div><div class="two-column-analysis-style-content-right">State grants for protection and advocacy services.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part F&mdash;Interagency Program for Trauma Research</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300d&ndash;61.</div><div class="two-column-analysis-style-content-right">Establishment of Program.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part G&mdash;Poison Control</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300d&ndash;71.</div><div class="two-column-analysis-style-content-right">Maintenance of a national toll-free number.</div></div>
<div><div class="two-column-analysis-style-content-left">300d&ndash;72.</div><div class="two-column-analysis-style-content-right">Nationwide media campaign to promote poison control center utilization.</div></div>
<div><div class="two-column-analysis-style-content-left">300d&ndash;73.</div><div class="two-column-analysis-style-content-right">Maintenance of the poison control center grant program.</div></div>
<div><div class="two-column-analysis-style-content-left">300d&ndash;74.</div><div class="two-column-analysis-style-content-right">Rule of construction.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="analysis-subhead">SUBCHAPTER XI&mdash;HEALTH MAINTENANCE ORGANIZATIONS</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300e.</div><div class="two-column-analysis-style-content-right">Requirements of health maintenance organizations.</div></div>
<div><div class="two-column-analysis-style-content-left">300e&ndash;1.</div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
<div><div class="two-column-analysis-style-content-left">300e&ndash;2, 300e&ndash;3.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">300e&ndash;4.</div><div class="two-column-analysis-style-content-right">Loans and loan guarantees for initial operation costs.</div></div>
<div><div class="two-column-analysis-style-content-left">300e&ndash;4a.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">300e&ndash;5.</div><div class="two-column-analysis-style-content-right">Application requirements.<!-- PDFPage:25 --></div></div>
<div><div class="two-column-analysis-style-content-left">300e&ndash;6.</div><div class="two-column-analysis-style-content-right">Administration of assistance programs.</div></div>
<div><div class="two-column-analysis-style-content-left">300e&ndash;7.</div><div class="two-column-analysis-style-content-right">General provisions relating to loan guarantees and loans.</div></div>
<div><div class="two-column-analysis-style-content-left">300e&ndash;8.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations.</div></div>
<div><div class="two-column-analysis-style-content-left">300e&ndash;9.</div><div class="two-column-analysis-style-content-right">Employees&rsquo; health benefits plans.</div></div>
<div><div class="two-column-analysis-style-content-left">300e&ndash;10.</div><div class="two-column-analysis-style-content-right">Restrictive State laws and practices.</div></div>
<div><div class="two-column-analysis-style-content-left">300e&ndash;11.</div><div class="two-column-analysis-style-content-right">Continued regulation of health maintenance organizations.</div></div>
<div><div class="two-column-analysis-style-content-left">300e&ndash;12.</div><div class="two-column-analysis-style-content-right">Limitation on source of funding for health maintenance organizations.</div></div>
<div><div class="two-column-analysis-style-content-left">300e&ndash;13.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">300e&ndash;14.</div><div class="two-column-analysis-style-content-right">Annual report.</div></div>
<div><div class="two-column-analysis-style-content-left">300e&ndash;14a.</div><div class="two-column-analysis-style-content-right">Health services for Indians and domestic agricultural migratory and seasonal workers.</div></div>
<div><div class="two-column-analysis-style-content-left">300e&ndash;15.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">300e&ndash;16.</div><div class="two-column-analysis-style-content-right">Training and technical assistance.</div></div>
<div><div class="two-column-analysis-style-content-left">300e&ndash;17.</div><div class="two-column-analysis-style-content-right">Financial disclosure.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="analysis-subhead">SUBCHAPTER XII&mdash;SAFETY OF PUBLIC WATER SYSTEMS</h4>
<h4 class="note-head">Part A&mdash;Definitions</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300f.</div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part B&mdash;Public Water Systems</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300g.</div><div class="two-column-analysis-style-content-right">Coverage.</div></div>
<div><div class="two-column-analysis-style-content-left">300g&ndash;1.</div><div class="two-column-analysis-style-content-right">National drinking water regulations.</div></div>
<div><div class="two-column-analysis-style-content-left">300g&ndash;2.</div><div class="two-column-analysis-style-content-right">State primary enforcement responsibility.</div></div>
<div><div class="two-column-analysis-style-content-left">300g&ndash;3.</div><div class="two-column-analysis-style-content-right">Enforcement of drinking water regulations.</div></div>
<div><div class="two-column-analysis-style-content-left">300g&ndash;4.</div><div class="two-column-analysis-style-content-right">Variances.</div></div>
<div><div class="two-column-analysis-style-content-left">300g&ndash;5.</div><div class="two-column-analysis-style-content-right">Exemptions.</div></div>
<div><div class="two-column-analysis-style-content-left">300g&ndash;6.</div><div class="two-column-analysis-style-content-right">Prohibition on use of lead pipes, solder, and flux.</div></div>
<div><div class="two-column-analysis-style-content-left">300g&ndash;7.</div><div class="two-column-analysis-style-content-right">Monitoring of contaminants.</div></div>
<div><div class="two-column-analysis-style-content-left">300g&ndash;8.</div><div class="two-column-analysis-style-content-right">Operator certification.</div></div>
<div><div class="two-column-analysis-style-content-left">300g&ndash;9.</div><div class="two-column-analysis-style-content-right">Capacity development.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part C&mdash;Protection of Underground Sources of Drinking Water</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300h.</div><div class="two-column-analysis-style-content-right">Regulations for State programs.</div></div>
<div><div class="two-column-analysis-style-content-left">300h&ndash;1.</div><div class="two-column-analysis-style-content-right">State primary enforcement responsibility.</div></div>
<div><div class="two-column-analysis-style-content-left">300h&ndash;2.</div><div class="two-column-analysis-style-content-right">Enforcement of program.</div></div>
<div><div class="two-column-analysis-style-content-left">300h&ndash;3.</div><div class="two-column-analysis-style-content-right">Interim regulation of underground injections.</div></div>
<div><div class="two-column-analysis-style-content-left">300h&ndash;4.</div><div class="two-column-analysis-style-content-right">Optional demonstration by States relating to oil or natural gas.</div></div>
<div><div class="two-column-analysis-style-content-left">300h&ndash;5.</div><div class="two-column-analysis-style-content-right">Regulation of State programs.</div></div>
<div><div class="two-column-analysis-style-content-left">300h&ndash;6.</div><div class="two-column-analysis-style-content-right">Sole source aquifer demonstration program.</div></div>
<div><div class="two-column-analysis-style-content-left">300h&ndash;7.</div><div class="two-column-analysis-style-content-right">State programs to establish wellhead protection areas.</div></div>
<div><div class="two-column-analysis-style-content-left">300h&ndash;8.</div><div class="two-column-analysis-style-content-right">State ground water protection grants.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part D&mdash;Emergency Powers</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300i.</div><div class="two-column-analysis-style-content-right">Emergency powers.</div></div>
<div><div class="two-column-analysis-style-content-left">300i&ndash;1.</div><div class="two-column-analysis-style-content-right">Tampering with public water systems.</div></div>
<div><div class="two-column-analysis-style-content-left">300i&ndash;2.</div><div class="two-column-analysis-style-content-right">Terrorist and other intentional acts.</div></div>
<div><div class="two-column-analysis-style-content-left">300i&ndash;3.</div><div class="two-column-analysis-style-content-right">Contaminant prevention, detection and response.</div></div>
<div><div class="two-column-analysis-style-content-left">300i&ndash;4.</div><div class="two-column-analysis-style-content-right">Supply disruption prevention, detection and response.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part E&mdash;General Provisions</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300j.</div><div class="two-column-analysis-style-content-right">Assurances of availability of adequate supplies of chemicals necessary for treatment of water.</div></div>
<div><div class="two-column-analysis-style-content-left">300j&ndash;1.</div><div class="two-column-analysis-style-content-right">Research, technical assistance, information, training of personnel.</div></div>
<div><div class="two-column-analysis-style-content-left">300j&ndash;2.</div><div class="two-column-analysis-style-content-right">Grants for State programs.</div></div>
<div><div class="two-column-analysis-style-content-left">300j&ndash;3.</div><div class="two-column-analysis-style-content-right">Special project grants and guaranteed loans.</div></div>
<div><div class="two-column-analysis-style-content-left">300j&ndash;3a.</div><div class="two-column-analysis-style-content-right">Grants to public sector agencies.</div></div>
<div><div class="two-column-analysis-style-content-left">300j&ndash;3b.</div><div class="two-column-analysis-style-content-right">Contaminant standards or treatment technique guidelines.</div></div>
<div><div class="two-column-analysis-style-content-left">300j&ndash;3c.</div><div class="two-column-analysis-style-content-right">National assistance program for water infrastructure and watersheds.</div></div>
<div><div class="two-column-analysis-style-content-left">300j&ndash;4.</div><div class="two-column-analysis-style-content-right">Records and inspections.</div></div>
<div><div class="two-column-analysis-style-content-left">300j&ndash;5.</div><div class="two-column-analysis-style-content-right">National Drinking Water Advisory Council.</div></div>
<div><div class="two-column-analysis-style-content-left">300j&ndash;6.</div><div class="two-column-analysis-style-content-right">Federal agencies.</div></div>
<div><div class="two-column-analysis-style-content-left">300j&ndash;7.</div><div class="two-column-analysis-style-content-right">Judicial review.</div></div>
<div><div class="two-column-analysis-style-content-left">300j&ndash;8.</div><div class="two-column-analysis-style-content-right">Citizen's civil action.</div></div>
<div><div class="two-column-analysis-style-content-left">300j&ndash;9.</div><div class="two-column-analysis-style-content-right">General provisions.</div></div>
<div><div class="two-column-analysis-style-content-left">300j&ndash;10.</div><div class="two-column-analysis-style-content-right">Appointment of scientific, etc., personnel by Administrator of Environmental Protection Agency for implementation of responsibilities; compensation.</div></div>
<div><div class="two-column-analysis-style-content-left">300j&ndash;11.</div><div class="two-column-analysis-style-content-right">Indian Tribes.</div></div>
<div><div class="two-column-analysis-style-content-left">300j&ndash;12.</div><div class="two-column-analysis-style-content-right">State revolving loan funds.</div></div>
<div><div class="two-column-analysis-style-content-left">300j&ndash;13.</div><div class="two-column-analysis-style-content-right">Source water quality assessment.</div></div>
<div><div class="two-column-analysis-style-content-left">300j&ndash;14.</div><div class="two-column-analysis-style-content-right">Source water petition program.</div></div>
<div><div class="two-column-analysis-style-content-left">300j&ndash;15.</div><div class="two-column-analysis-style-content-right">Water conservation plan.</div></div>
<div><div class="two-column-analysis-style-content-left">300j&ndash;16.</div><div class="two-column-analysis-style-content-right">Assistance to colonias.</div></div>
<div><div class="two-column-analysis-style-content-left">300j&ndash;17.</div><div class="two-column-analysis-style-content-right">Estrogenic substances screening program.</div></div>
<div><div class="two-column-analysis-style-content-left">300j&ndash;18.</div><div class="two-column-analysis-style-content-right">Drinking water studies.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part F&mdash;Additional Requirements To Regulate Safety of Drinking Water</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300j&ndash;21.</div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
<div><div class="two-column-analysis-style-content-left">300j&ndash;22.</div><div class="two-column-analysis-style-content-right">Recall of drinking water coolers with lead-lined tanks.</div></div>
<div><div class="two-column-analysis-style-content-left">300j&ndash;23.</div><div class="two-column-analysis-style-content-right">Drinking water coolers containing lead.</div></div>
<div><div class="two-column-analysis-style-content-left">300j&ndash;24.</div><div class="two-column-analysis-style-content-right">Lead contamination in school drinking water.</div></div>
<div><div class="two-column-analysis-style-content-left">300j&ndash;25.</div><div class="two-column-analysis-style-content-right">Federal assistance for State programs regarding lead contamination in school drinking water.</div></div>
<div><div class="two-column-analysis-style-content-left">300j&ndash;26.</div><div class="two-column-analysis-style-content-right">Certification of testing laboratories.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="analysis-subhead">SUBCHAPTER XIII&mdash;PREVENTIVE HEALTH MEASURES WITH RESPECT TO BREAST AND CERVICAL CANCERS</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300k.</div><div class="two-column-analysis-style-content-right">Establishment of program of grants to States.</div></div>
<div><div class="two-column-analysis-style-content-left">300<em>l.</em></div><div class="two-column-analysis-style-content-right">Requirement of matching funds.</div></div>
<div><div class="two-column-analysis-style-content-left">300<em>l</em>&ndash;1.</div><div class="two-column-analysis-style-content-right">Requirement regarding medicaid.</div></div>
<div><div class="two-column-analysis-style-content-left">300m.</div><div class="two-column-analysis-style-content-right">Requirements with respect to type and quality of services.</div></div>
<div><div class="two-column-analysis-style-content-left">300n.</div><div class="two-column-analysis-style-content-right">Additional required agreements.</div></div>
<div><div class="two-column-analysis-style-content-left">300n&ndash;1.</div><div class="two-column-analysis-style-content-right">Description of intended uses of grant.</div></div>
<div><div class="two-column-analysis-style-content-left">300n&ndash;2.</div><div class="two-column-analysis-style-content-right">Requirement of submission of application.</div></div>
<div><div class="two-column-analysis-style-content-left">300n&ndash;3.</div><div class="two-column-analysis-style-content-right">Technical assistance and provision of supplies and services in lieu of grant funds.</div></div>
<div><div class="two-column-analysis-style-content-left">300n&ndash;4.</div><div class="two-column-analysis-style-content-right">Evaluations and reports.</div></div>
<div><div class="two-column-analysis-style-content-left">300n&ndash;4a.</div><div class="two-column-analysis-style-content-right">Supplemental grants for additional preventive health services.</div></div>
<div><div class="two-column-analysis-style-content-left">300n&ndash;5.</div><div class="two-column-analysis-style-content-right">Funding for general program.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="analysis-subhead">SUBCHAPTER XIV&mdash;HEALTH RESOURCES DEVELOPMENT</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300<em>o</em> to 300p&ndash;3.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part A&mdash;Loans and Loan Guarantees</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300q.</div><div class="two-column-analysis-style-content-right">Loan and loan guarantee authority.</div></div>
<div><div class="two-column-analysis-style-content-left">300q&ndash;1.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">300q&ndash;2.</div><div class="two-column-analysis-style-content-right">General provisions.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part B&mdash;Project Grants</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300r.</div><div class="two-column-analysis-style-content-right">Grants for construction or modernization projects.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part C&mdash;General Provisions</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300s.</div><div class="two-column-analysis-style-content-right">General regulations.</div></div>
<div><div class="two-column-analysis-style-content-left">300s&ndash;1.</div><div class="two-column-analysis-style-content-right">Medical facility project applications.</div></div>
<div><div class="two-column-analysis-style-content-left">300s&ndash;1a.</div><div class="two-column-analysis-style-content-right">Recovery of expenditures under certain conditions.</div></div>
<div><div class="two-column-analysis-style-content-left">300s&ndash;2.</div><div class="two-column-analysis-style-content-right">State supervision or control of operations of facilities receiving funds.<!-- PDFPage:26 --></div></div>
<div><div class="two-column-analysis-style-content-left">300s&ndash;3.</div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
<div><div class="two-column-analysis-style-content-left">300s&ndash;4.</div><div class="two-column-analysis-style-content-right">Reporting and audit requirements for recipients.</div></div>
<div><div class="two-column-analysis-style-content-left">300s&ndash;5.</div><div class="two-column-analysis-style-content-right">Availability of technical and other nonfinancial assistance to eligible applicants.</div></div>
<div><div class="two-column-analysis-style-content-left">300s&ndash;6.</div><div class="two-column-analysis-style-content-right">Enforcement of assurances.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part D&mdash;Area Health Services Development Funds</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300t.</div><div class="two-column-analysis-style-content-right">Development grants for health systems agencies.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part E&mdash;Program To Assist and Encourage Voluntary Discontinuance of Unneeded Hospital Services and Conversion of Unneeded Hospital Services to Other Health Services Needed by Community</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300t&ndash;11.</div><div class="two-column-analysis-style-content-right">Grants and assistance for establishment of program.</div></div>
<div><div class="two-column-analysis-style-content-left">300t&ndash;12.</div><div class="two-column-analysis-style-content-right">Grants for discontinuance and conversion.</div></div>
<div><div class="two-column-analysis-style-content-left">300t&ndash;13.</div><div class="two-column-analysis-style-content-right">Grants to States for reduction of excess hospital capacity.</div></div>
<div><div class="two-column-analysis-style-content-left">300t&ndash;14.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="analysis-subhead">SUBCHAPTER XV&mdash;HEALTH INFORMATION AND HEALTH PROMOTION</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300u.</div><div class="two-column-analysis-style-content-right">General authority of Secretary.</div></div>
<div><div class="two-column-analysis-style-content-left">300u&ndash;1.</div><div class="two-column-analysis-style-content-right">Grants and contracts for research programs; authority of Secretary; review of applications; additional functions; periodic public survey.</div></div>
<div><div class="two-column-analysis-style-content-left">300u&ndash;2.</div><div class="two-column-analysis-style-content-right">Grants and contracts for community health programs.</div></div>
<div><div class="two-column-analysis-style-content-left">300u&ndash;3.</div><div class="two-column-analysis-style-content-right">Grants and contracts for information programs; authority of Secretary; particular activities.</div></div>
<div><div class="two-column-analysis-style-content-left">300u&ndash;4.</div><div class="two-column-analysis-style-content-right">Status reports to President and Congress; study of health education and preventive health services with respect to insurance coverage.</div></div>
<div><div class="two-column-analysis-style-content-left">300u&ndash;5.</div><div class="two-column-analysis-style-content-right">Centers for research and demonstration of health promotion and disease prevention.</div></div>
<div><div class="two-column-analysis-style-content-left">300u&ndash;6.</div><div class="two-column-analysis-style-content-right">Office of Minority Health.</div></div>
<div><div class="two-column-analysis-style-content-left">300u&ndash;7.</div><div class="two-column-analysis-style-content-right">Office of Adolescent Health.</div></div>
<div><div class="two-column-analysis-style-content-left">300u&ndash;8.</div><div class="two-column-analysis-style-content-right">Biennial report regarding nutrition and health.</div></div>
<div><div class="two-column-analysis-style-content-left">300u&ndash;9.</div><div class="two-column-analysis-style-content-right">Education regarding DES.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="analysis-subhead">SUBCHAPTER XVI&mdash;PRESIDENT'S COMMISSION FOR THE STUDY OF ETHICAL PROBLEMS IN MEDICINE AND BIOMEDICAL AND BEHAVIOR RESEARCH</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300v.</div><div class="two-column-analysis-style-content-right">Commission.</div></div>
<div><div class="two-column-analysis-style-content-left">300v&ndash;1.</div><div class="two-column-analysis-style-content-right">Duties of Commission.</div></div>
<div><div class="two-column-analysis-style-content-left">300v&ndash;2.</div><div class="two-column-analysis-style-content-right">Administrative provisions.</div></div>
<div><div class="two-column-analysis-style-content-left">300v&ndash;3.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations; termination of Commission.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="analysis-subhead">SUBCHAPTER XVII&mdash;BLOCK GRANTS</h4>
<h4 class="note-head">Part A&mdash;Preventive Health and Health Services Block Grants</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300w.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations.</div></div>
<div><div class="two-column-analysis-style-content-left">300w&ndash;1.</div><div class="two-column-analysis-style-content-right">Allotments.</div></div>
<div><div class="two-column-analysis-style-content-left">300w&ndash;2.</div><div class="two-column-analysis-style-content-right">Payments under allotments to States.</div></div>
<div><div class="two-column-analysis-style-content-left">300w&ndash;3.</div><div class="two-column-analysis-style-content-right">Use of allotments.</div></div>
<div><div class="two-column-analysis-style-content-left">300w&ndash;4.</div><div class="two-column-analysis-style-content-right">Application for payments; State plan.</div></div>
<div><div class="two-column-analysis-style-content-left">300w&ndash;5.</div><div class="two-column-analysis-style-content-right">Reports, data, and audits.</div></div>
<div><div class="two-column-analysis-style-content-left">300w&ndash;6.</div><div class="two-column-analysis-style-content-right">Withholding of funds.</div></div>
<div><div class="two-column-analysis-style-content-left">300w&ndash;7.</div><div class="two-column-analysis-style-content-right">Nondiscrimination provisions.</div></div>
<div><div class="two-column-analysis-style-content-left">300w&ndash;8.</div><div class="two-column-analysis-style-content-right">Criminal penalty for false statements.</div></div>
<div><div class="two-column-analysis-style-content-left">300w&ndash;9.</div><div class="two-column-analysis-style-content-right">Emergency medical services for children.</div></div>
<div><div class="two-column-analysis-style-content-left">300w&ndash;10.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part B&mdash;Block Grants Regarding Mental Health and Substance Abuse</h4>
I74subpart i&mdash;block grants for community mental health services<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300x.</div><div class="two-column-analysis-style-content-right">Formula grants to States.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;1.</div><div class="two-column-analysis-style-content-right">State plan for comprehensive community mental health services for certain individuals.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;2.</div><div class="two-column-analysis-style-content-right">Certain agreements.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;3.</div><div class="two-column-analysis-style-content-right">State mental health planning council.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;4.</div><div class="two-column-analysis-style-content-right">Additional provisions.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;5.</div><div class="two-column-analysis-style-content-right">Restrictions on use of payments.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;6.</div><div class="two-column-analysis-style-content-right">Application for grant.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;7.</div><div class="two-column-analysis-style-content-right">Determination of amount of allotment.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;8.</div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;9.</div><div class="two-column-analysis-style-content-right">Funding.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart ii&mdash;block grants for prevention and treatment of substance abuse</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300x&ndash;21.</div><div class="two-column-analysis-style-content-right">Formula grants to States.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;22.</div><div class="two-column-analysis-style-content-right">Certain allocations.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;23.</div><div class="two-column-analysis-style-content-right">Intravenous substance abuse.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;24.</div><div class="two-column-analysis-style-content-right">Requirements regarding tuberculosis and human immunodeficiency virus.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;25.</div><div class="two-column-analysis-style-content-right">Group homes for recovering substance abusers.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;26.</div><div class="two-column-analysis-style-content-right">State law regarding sale of tobacco products to individuals under age of 18.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;27.</div><div class="two-column-analysis-style-content-right">Treatment services for pregnant women.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;28.</div><div class="two-column-analysis-style-content-right">Additional agreements.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;29.</div><div class="two-column-analysis-style-content-right">Submission to Secretary of statewide assessment of needs.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;30.</div><div class="two-column-analysis-style-content-right">Maintenance of effort regarding State expenditures.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;31.</div><div class="two-column-analysis-style-content-right">Restrictions on expenditure of grant.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;32.</div><div class="two-column-analysis-style-content-right">Application for grant; approval of State plan.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;33.</div><div class="two-column-analysis-style-content-right">Determination of amount of allotment.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;34.</div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;35.</div><div class="two-column-analysis-style-content-right">Funding.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart iii&mdash;general provisions</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300x&ndash;51.</div><div class="two-column-analysis-style-content-right">Opportunity for public comment on State plans.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;52.</div><div class="two-column-analysis-style-content-right">Requirement of reports and audits by States.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;53.</div><div class="two-column-analysis-style-content-right">Additional requirements.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;54.</div><div class="two-column-analysis-style-content-right">Disposition of certain funds appropriated for allotments.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;55.</div><div class="two-column-analysis-style-content-right">Failure to comply with agreements.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;56.</div><div class="two-column-analysis-style-content-right">Prohibitions regarding receipt of funds.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;57.</div><div class="two-column-analysis-style-content-right">Nondiscrimination.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;58.</div><div class="two-column-analysis-style-content-right">Technical assistance and provision of supplies and services in lieu of grant funds.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;59.</div><div class="two-column-analysis-style-content-right">Plans for performance partnerships.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;60.</div><div class="two-column-analysis-style-content-right">Rule of construction regarding delegation of authority to States.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;61.</div><div class="two-column-analysis-style-content-right">Solicitation of views of certain entities.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;62.</div><div class="two-column-analysis-style-content-right">Availability to States of grant payments.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;63.</div><div class="two-column-analysis-style-content-right">Continuation of certain programs.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;64.</div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;65.</div><div class="two-column-analysis-style-content-right">Services provided by nongovernmental organizations.</div></div>
<div><div class="two-column-analysis-style-content-left">300x&ndash;66.</div><div class="two-column-analysis-style-content-right">Services for individuals with co-occurring disorders.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part C&mdash;Certain Programs Regarding Mental Health and Substance Abuse</h4>
I74subpart i&mdash;data infrastructure development<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300y.</div><div class="two-column-analysis-style-content-right">Data infrastructure development.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart ii&mdash;interim maintenance treatment of narcotics dependence</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300y&ndash;11.</div><div class="two-column-analysis-style-content-right">Interim maintenance treatment.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="analysis-subhead">SUBCHAPTER XVIII&mdash;ADOLESCENT FAMILY LIFE DEMONSTRATION PROJECTS</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300z.</div><div class="two-column-analysis-style-content-right">Findings and purposes.</div></div>
<div><div class="two-column-analysis-style-content-left">300z&ndash;1.</div><div class="two-column-analysis-style-content-right">Definitions; regulations applicable.</div></div>
<div><div class="two-column-analysis-style-content-left">300z&ndash;2.</div><div class="two-column-analysis-style-content-right">Demonstration projects; grant authorization, etc.<!-- PDFPage:27 --></div></div>
<div><div class="two-column-analysis-style-content-left">300z&ndash;3.</div><div class="two-column-analysis-style-content-right">Uses of grants for demonstration projects for services.</div></div>
<div><div class="two-column-analysis-style-content-left">300z&ndash;4.</div><div class="two-column-analysis-style-content-right">Grants for demonstration projects for services.</div></div>
<div><div class="two-column-analysis-style-content-left">300z&ndash;5.</div><div class="two-column-analysis-style-content-right">Requirements for applications.</div></div>
<div><div class="two-column-analysis-style-content-left">300z&ndash;6.</div><div class="two-column-analysis-style-content-right">Coordination of programs.</div></div>
<div><div class="two-column-analysis-style-content-left">300z&ndash;7.</div><div class="two-column-analysis-style-content-right">Research.</div></div>
<div><div class="two-column-analysis-style-content-left">300z&ndash;8.</div><div class="two-column-analysis-style-content-right">Evaluation and administration.</div></div>
<div><div class="two-column-analysis-style-content-left">300z&ndash;9.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations.</div></div>
<div><div class="two-column-analysis-style-content-left">300z&ndash;10.</div><div class="two-column-analysis-style-content-right">Restrictions.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="analysis-subhead">SUBCHAPTER XIX&mdash;VACCINES</h4>
<h4 class="note-head">Part 1&mdash;National Vaccine Program</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300aa&ndash;1.</div><div class="two-column-analysis-style-content-right">Establishment.</div></div>
<div><div class="two-column-analysis-style-content-left">300aa&ndash;2.</div><div class="two-column-analysis-style-content-right">Program responsibilities.</div></div>
<div><div class="two-column-analysis-style-content-left">300aa&ndash;3.</div><div class="two-column-analysis-style-content-right">Plan.</div></div>
<div><div class="two-column-analysis-style-content-left">300aa&ndash;4.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">300aa&ndash;5.</div><div class="two-column-analysis-style-content-right">National Vaccine Advisory Committee.</div></div>
<div><div class="two-column-analysis-style-content-left">300aa&ndash;6.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part 2&mdash;National Vaccine Injury Compensation Program</h4>
I74subpart a&mdash;program requirements<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300aa&ndash;10.</div><div class="two-column-analysis-style-content-right">Establishment of program.</div></div>
<div><div class="two-column-analysis-style-content-left">300aa&ndash;11.</div><div class="two-column-analysis-style-content-right">Petitions for compensation.</div></div>
<div><div class="two-column-analysis-style-content-left">300aa&ndash;12.</div><div class="two-column-analysis-style-content-right">Court jurisdiction.</div></div>
<div><div class="two-column-analysis-style-content-left">300aa&ndash;13.</div><div class="two-column-analysis-style-content-right">Determination of eligibility and compensation.</div></div>
<div><div class="two-column-analysis-style-content-left">300aa&ndash;14.</div><div class="two-column-analysis-style-content-right">Vaccine Injury Table.</div></div>
<div><div class="two-column-analysis-style-content-left">300aa&ndash;15.</div><div class="two-column-analysis-style-content-right">Compensation.</div></div>
<div><div class="two-column-analysis-style-content-left">300aa&ndash;16.</div><div class="two-column-analysis-style-content-right">Limitations of actions.</div></div>
<div><div class="two-column-analysis-style-content-left">300aa&ndash;17.</div><div class="two-column-analysis-style-content-right">Subrogation.</div></div>
<div><div class="two-column-analysis-style-content-left">300aa&ndash;18.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">300aa&ndash;19.</div><div class="two-column-analysis-style-content-right">Advisory Commission on Childhood Vaccines.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart b&mdash;additional remedies</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300aa&ndash;21.</div><div class="two-column-analysis-style-content-right">Authority to bring actions.</div></div>
<div><div class="two-column-analysis-style-content-left">300aa&ndash;22.</div><div class="two-column-analysis-style-content-right">Standards of responsibility.</div></div>
<div><div class="two-column-analysis-style-content-left">300aa&ndash;23.</div><div class="two-column-analysis-style-content-right">Trial.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart c&mdash;assuring a safer childhood vaccination program in united states</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300aa&ndash;25.</div><div class="two-column-analysis-style-content-right">Recording and reporting of information.</div></div>
<div><div class="two-column-analysis-style-content-left">300aa&ndash;26.</div><div class="two-column-analysis-style-content-right">Vaccine information.</div></div>
<div><div class="two-column-analysis-style-content-left">300aa&ndash;27.</div><div class="two-column-analysis-style-content-right">Mandate for safer childhood vaccines.</div></div>
<div><div class="two-column-analysis-style-content-left">300aa&ndash;28.</div><div class="two-column-analysis-style-content-right">Manufacturer recordkeeping and reporting.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart d&mdash;general provisions</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300aa&ndash;31.</div><div class="two-column-analysis-style-content-right">Citizen's actions.</div></div>
<div><div class="two-column-analysis-style-content-left">300aa&ndash;32.</div><div class="two-column-analysis-style-content-right">Judicial review.</div></div>
<div><div class="two-column-analysis-style-content-left">300aa&ndash;33.</div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
<div><div class="two-column-analysis-style-content-left">300aa&ndash;34.</div><div class="two-column-analysis-style-content-right">Termination of program.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="analysis-subhead">SUBCHAPTER XX&mdash;REQUIREMENTS FOR CERTAIN GROUP HEALTH PLANS FOR CERTAIN STATE AND LOCAL EMPLOYEES</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300bb&ndash;1.</div><div class="two-column-analysis-style-content-right">State and local governmental group health plans must provide continuation coverage to certain individuals.</div></div>
<div><div class="two-column-analysis-style-content-left">300bb&ndash;2.</div><div class="two-column-analysis-style-content-right">Continuation coverage.</div></div>
<div><div class="two-column-analysis-style-content-left">300bb&ndash;3.</div><div class="two-column-analysis-style-content-right">Qualifying event.</div></div>
<div><div class="two-column-analysis-style-content-left">300bb&ndash;4.</div><div class="two-column-analysis-style-content-right">Applicable premium.</div></div>
<div><div class="two-column-analysis-style-content-left">300bb&ndash;5.</div><div class="two-column-analysis-style-content-right">Election.</div></div>
<div><div class="two-column-analysis-style-content-left">300bb&ndash;6.</div><div class="two-column-analysis-style-content-right">Notice requirements.</div></div>
<div><div class="two-column-analysis-style-content-left">300bb&ndash;7.</div><div class="two-column-analysis-style-content-right">Enforcement.</div></div>
<div><div class="two-column-analysis-style-content-left">300bb&ndash;8.</div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="analysis-subhead">SUBCHAPTER XXI&mdash;RESEARCH WITH RESPECT TO ACQUIRED IMMUNE DEFICIENCY SYNDROME</h4>
<h4 class="note-head">Part A&mdash;Administration of Research Programs</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300cc.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">300cc&ndash;1.</div><div class="two-column-analysis-style-content-right">Requirement of expediting awards of grants and contracts for research.</div></div>
<div><div class="two-column-analysis-style-content-left">300cc&ndash;2.</div><div class="two-column-analysis-style-content-right">Requirements with respect to processing of requests for personnel and administrative support.</div></div>
<div><div class="two-column-analysis-style-content-left">300cc&ndash;3.</div><div class="two-column-analysis-style-content-right">Establishment of Research Advisory Committee.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part B&mdash;Research Authority</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300cc&ndash;11.</div><div class="two-column-analysis-style-content-right">Clinical evaluation units at National Institutes of Health.</div></div>
<div><div class="two-column-analysis-style-content-left">300cc&ndash;12.</div><div class="two-column-analysis-style-content-right">Use of investigational new drugs with respect to acquired immune deficiency syndrome.</div></div>
<div><div class="two-column-analysis-style-content-left">300cc&ndash;13.</div><div class="two-column-analysis-style-content-right">Terry Beirn Community-Based AIDS Research Initiative.</div></div>
<div><div class="two-column-analysis-style-content-left">300cc&ndash;14.</div><div class="two-column-analysis-style-content-right">Evaluation of certain treatments.</div></div>
<div><div class="two-column-analysis-style-content-left">300cc&ndash;15.</div><div class="two-column-analysis-style-content-right">Support of international efforts.</div></div>
<div><div class="two-column-analysis-style-content-left">300cc&ndash;16.</div><div class="two-column-analysis-style-content-right">Research centers.</div></div>
<div><div class="two-column-analysis-style-content-left">300cc&ndash;17.</div><div class="two-column-analysis-style-content-right">Information services.</div></div>
<div><div class="two-column-analysis-style-content-left">300cc&ndash;18.</div><div class="two-column-analysis-style-content-right">Development of model protocols for clinical care of infected individuals.</div></div>
<div><div class="two-column-analysis-style-content-left">300cc&ndash;19.</div><div class="two-column-analysis-style-content-right">National blood resource education program.</div></div>
<div><div class="two-column-analysis-style-content-left">300cc&ndash;20.</div><div class="two-column-analysis-style-content-right">Additional authority with respect to research.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part C&mdash;Research Training</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300cc&ndash;31.</div><div class="two-column-analysis-style-content-right">Fellowships and training.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part D&mdash;Office of AIDS Research</h4>
I74subpart i&mdash;interagency coordination of activities<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300cc&ndash;40.</div><div class="two-column-analysis-style-content-right">Establishment of Office.</div></div>
<div><div class="two-column-analysis-style-content-left">300cc&ndash;40a.</div><div class="two-column-analysis-style-content-right">Advisory Council; coordinating committees.</div></div>
<div><div class="two-column-analysis-style-content-left">300cc&ndash;40b.</div><div class="two-column-analysis-style-content-right">Comprehensive plan for expenditure of appropriations.</div></div>
<div><div class="two-column-analysis-style-content-left">300cc&ndash;41.</div><div class="two-column-analysis-style-content-right">Additional authorities.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart ii&mdash;emergency discretionary fund</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300cc&ndash;43.</div><div class="two-column-analysis-style-content-right">Emergency Discretionary Fund.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart iii&mdash;general provisions</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300cc&ndash;45.</div><div class="two-column-analysis-style-content-right">General provisions regarding Office.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part E&mdash;General Provisions</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300cc&ndash;51.</div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="analysis-subhead">SUBCHAPTER XXII&mdash;HEALTH SERVICES WITH RESPECT TO ACQUIRED IMMUNE DEFICIENCY SYNDROME</h4>
<h4 class="note-head">Part A&mdash;Formula Grants to States for Home and Community-Based Health Services</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left" id="wide">300dd to 300dd&ndash;14. Repealed.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part B&mdash;Subacute Care</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300dd&ndash;21.</div><div class="two-column-analysis-style-content-right">Demonstration projects.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part C&mdash;Other Health Services</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300dd&ndash;31.</div><div class="two-column-analysis-style-content-right">Grants for anonymous testing.</div></div>
<div><div class="two-column-analysis-style-content-left">300dd&ndash;32.</div><div class="two-column-analysis-style-content-right">Requirement of provision of certain counseling services.</div></div>
<div><div class="two-column-analysis-style-content-left">300dd&ndash;33.</div><div class="two-column-analysis-style-content-right">Funding.</div></div>
<div><div class="two-column-analysis-style-content-left">300dd&ndash;41.</div><div class="two-column-analysis-style-content-right">Transferred.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="analysis-subhead">SUBCHAPTER XXIII&mdash;PREVENTION OF ACQUIRED IMMUNE DEFICIENCY SYNDROME</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300ee.</div><div class="two-column-analysis-style-content-right">Use of funds.</div></div>
<div><div class="two-column-analysis-style-content-left">300ee&ndash;1.</div><div class="two-column-analysis-style-content-right">Establishment of office with respect to minority health and acquired immune deficiency syndrome.</div></div>
<div><div class="two-column-analysis-style-content-left">300ee&ndash;2.</div><div class="two-column-analysis-style-content-right">Information for health and public safety workers.</div></div>
<div><div class="two-column-analysis-style-content-left">300ee&ndash;3.</div><div class="two-column-analysis-style-content-right">Continuing education for health care providers.</div></div>
<div><div class="two-column-analysis-style-content-left">300ee&ndash;4.</div><div class="two-column-analysis-style-content-right">Technical assistance.</div></div>
<div><div class="two-column-analysis-style-content-left">300ee&ndash;5.</div><div class="two-column-analysis-style-content-right">Use of funds to supply hypodermic needles or syringes for illegal drug use; prohibition.</div></div>
<div><div class="two-column-analysis-style-content-left">300ee&ndash;6.</div><div class="two-column-analysis-style-content-right">Transferred.<!-- PDFPage:28 --></div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part A&mdash;Formula Grants to States</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300ee&ndash;11.</div><div class="two-column-analysis-style-content-right">Establishment of program.</div></div>
<div><div class="two-column-analysis-style-content-left">300ee&ndash;12.</div><div class="two-column-analysis-style-content-right">Provisions with respect to carrying out purpose of grants.</div></div>
<div><div class="two-column-analysis-style-content-left">300ee&ndash;13.</div><div class="two-column-analysis-style-content-right">Requirement of submission of application containing certain agreements and assurances.</div></div>
<div><div class="two-column-analysis-style-content-left">300ee&ndash;14.</div><div class="two-column-analysis-style-content-right">Restrictions on use of grant.</div></div>
<div><div class="two-column-analysis-style-content-left">300ee&ndash;15.</div><div class="two-column-analysis-style-content-right">Requirement of reports and audits by States.</div></div>
<div><div class="two-column-analysis-style-content-left">300ee&ndash;16.</div><div class="two-column-analysis-style-content-right">Additional required agreements.</div></div>
<div><div class="two-column-analysis-style-content-left">300ee&ndash;17.</div><div class="two-column-analysis-style-content-right">Determination of amount of allotments for States.</div></div>
<div><div class="two-column-analysis-style-content-left">300ee&ndash;18.</div><div class="two-column-analysis-style-content-right">Failure to comply with agreements.</div></div>
<div><div class="two-column-analysis-style-content-left">300ee&ndash;19.</div><div class="two-column-analysis-style-content-right">Prohibition against certain false statements.</div></div>
<div><div class="two-column-analysis-style-content-left">300ee&ndash;20.</div><div class="two-column-analysis-style-content-right">Technical assistance and provision by Secretary of supplies and services in lieu of grant funds.</div></div>
<div><div class="two-column-analysis-style-content-left">300ee&ndash;21.</div><div class="two-column-analysis-style-content-right">Evaluations.</div></div>
<div><div class="two-column-analysis-style-content-left">300ee&ndash;22.</div><div class="two-column-analysis-style-content-right">Report by Secretary.</div></div>
<div><div class="two-column-analysis-style-content-left">300ee&ndash;23.</div><div class="two-column-analysis-style-content-right">Definition.</div></div>
<div><div class="two-column-analysis-style-content-left">300ee&ndash;24.</div><div class="two-column-analysis-style-content-right">Funding.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part B&mdash;National Information Programs</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300ee&ndash;31.</div><div class="two-column-analysis-style-content-right">Availability of information to general public.</div></div>
<div><div class="two-column-analysis-style-content-left">300ee&ndash;32.</div><div class="two-column-analysis-style-content-right">Public information campaigns.</div></div>
<div><div class="two-column-analysis-style-content-left">300ee&ndash;33.</div><div class="two-column-analysis-style-content-right">Provision of information to underserved populations.</div></div>
<div><div class="two-column-analysis-style-content-left">300ee&ndash;34.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="analysis-subhead">SUBCHAPTER XXIV&mdash;HIV HEALTH CARE SERVICES PROGRAM</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300ff.</div><div class="two-column-analysis-style-content-right">Purpose.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;1.</div><div class="two-column-analysis-style-content-right">Prohibition on use of funds.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part A&mdash;Emergency Relief for Areas With Substantial Need for Services</h4>
I74subpart i&mdash;general grant provisions<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300ff&ndash;11.</div><div class="two-column-analysis-style-content-right">Establishment of program of grants.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;12.</div><div class="two-column-analysis-style-content-right">Administration and planning council.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;13.</div><div class="two-column-analysis-style-content-right">Type and distribution of grants.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;14.</div><div class="two-column-analysis-style-content-right">Use of amounts.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;15.</div><div class="two-column-analysis-style-content-right">Application.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;16.</div><div class="two-column-analysis-style-content-right">Technical assistance.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;17.</div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;18.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart ii&mdash;transitional grants</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300ff&ndash;19.</div><div class="two-column-analysis-style-content-right">Establishment of program.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart iii&mdash;general provisions</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300ff&ndash;20.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part B&mdash;Care Grant Program</h4>
I74subpart i&mdash;general grant provisions<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300ff&ndash;21.</div><div class="two-column-analysis-style-content-right">Grants.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;22.</div><div class="two-column-analysis-style-content-right">General use of grants.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;23.</div><div class="two-column-analysis-style-content-right">Grants to establish HIV care consortia.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;24.</div><div class="two-column-analysis-style-content-right">Grants for home- and community-based care.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;25.</div><div class="two-column-analysis-style-content-right">Continuum of health insurance coverage.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;26.</div><div class="two-column-analysis-style-content-right">Provision of treatments.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;27.</div><div class="two-column-analysis-style-content-right">State application.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;27a.</div><div class="two-column-analysis-style-content-right">Spousal notification.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;28.</div><div class="two-column-analysis-style-content-right">Distribution of funds.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;29.</div><div class="two-column-analysis-style-content-right">Technical assistance.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;29a.</div><div class="two-column-analysis-style-content-right">Supplemental grants.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;30.</div><div class="two-column-analysis-style-content-right">Emerging communities.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;31.</div><div class="two-column-analysis-style-content-right" id="wide">Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;31a.</div><div class="two-column-analysis-style-content-right">Timeframe for obligation and expenditure of grant funds.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;31b.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart ii&mdash;provisions concerning pregnancy and perinatal transmission of hiv</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300ff&ndash;33.</div><div class="two-column-analysis-style-content-right">Early diagnosis grant program.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;34.</div><div class="two-column-analysis-style-content-right">Perinatal transmission of HIV/AIDS; contingent requirement regarding State grants under this part.</div></div>
<div><div class="two-column-analysis-style-content-left" id="wide">300ff&ndash;35, 300ff&ndash;36. Repealed.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;37.</div><div class="two-column-analysis-style-content-right">State HIV testing programs established prior to or after May 20, 1996.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;37a.</div><div class="two-column-analysis-style-content-right">Recommendations for reducing incidence of perinatal transmission.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart iii&mdash;certain partner notification programs</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300ff&ndash;38.</div><div class="two-column-analysis-style-content-right">Grants for partner notification programs.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part C&mdash;Early Intervention Services</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left" id="wide">300ff&ndash;41 to 300ff&ndash;50. Repealed.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart i&mdash;categorical grants</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300ff&ndash;51.</div><div class="two-column-analysis-style-content-right">Establishment of a program.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;52.</div><div class="two-column-analysis-style-content-right">Minimum qualifications of grantees.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;53.</div><div class="two-column-analysis-style-content-right">Preferences in making grants.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;54.</div><div class="two-column-analysis-style-content-right">Miscellaneous provisions.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;55.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart ii&mdash;general provisions</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300ff&ndash;61.</div><div class="two-column-analysis-style-content-right">Confidentiality and informed consent.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;62.</div><div class="two-column-analysis-style-content-right">Provision of certain counseling services.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;63.</div><div class="two-column-analysis-style-content-right">Applicability of requirements regarding confidentiality, informed consent, and counseling.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;64.</div><div class="two-column-analysis-style-content-right">Additional required agreements.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;65.</div><div class="two-column-analysis-style-content-right">Requirement of submission of application containing certain agreements and assurances.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;66.</div><div class="two-column-analysis-style-content-right">Provision by Secretary of supplies and services in lieu of grant funds.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;67.</div><div class="two-column-analysis-style-content-right">Use of funds.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part D&mdash;Women, Infants, Children, and Youth</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300ff&ndash;71.</div><div class="two-column-analysis-style-content-right">Grants for coordinated services and access to research for women, infants, children, and youth.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part E&mdash;General Provisions</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300ff&ndash;81.</div><div class="two-column-analysis-style-content-right">Coordination.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;82.</div><div class="two-column-analysis-style-content-right">Audits.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;83.</div><div class="two-column-analysis-style-content-right">Public health emergency.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;84.</div><div class="two-column-analysis-style-content-right">Prohibition on promotion of certain activities.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;85.</div><div class="two-column-analysis-style-content-right">Privacy protections.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;86.</div><div class="two-column-analysis-style-content-right">GAO report.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;87.</div><div class="two-column-analysis-style-content-right">Severity of need index.</div></div>
<div><div class="two-column-analysis-style-content-left">300ff&ndash;88.</div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part F&mdash;Demonstration and Training</h4>
I74subpart i&mdash;special projects of national significance<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300ff&ndash;101.</div><div class="two-column-analysis-style-content-right">Special projects of national significance.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart ii&mdash;aids education and training centers</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300ff&ndash;111.</div><div class="two-column-analysis-style-content-right">HIV/AIDS communities, schools, and centers.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart iii&mdash;minority aids initiative</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300ff&ndash;121.</div><div class="two-column-analysis-style-content-right">Minority AIDS initiative.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="analysis-subhead">SUBCHAPTER XXV&mdash;REQUIREMENTS RELATING TO HEALTH INSURANCE COVERAGE</h4>
<h4 class="note-head">Part A&mdash;Group Market Reforms</h4>
I74subpart 1&mdash;portability, access, and renewability requirements<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300gg.</div><div class="two-column-analysis-style-content-right">Increased portability through limitation on preexisting condition exclusions.</div></div>
<div><div class="two-column-analysis-style-content-left">300gg&ndash;1.</div><div class="two-column-analysis-style-content-right">Prohibiting discrimination against individual participants and beneficiaries based on health status.<!-- PDFPage:29 --></div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 2&mdash;other requirements</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300gg&ndash;4.</div><div class="two-column-analysis-style-content-right">Standards relating to benefits for mothers and newborns.</div></div>
<div><div class="two-column-analysis-style-content-left">300gg&ndash;5.</div><div class="two-column-analysis-style-content-right">Parity in application of certain limits to mental health benefits.</div></div>
<div><div class="two-column-analysis-style-content-left">300gg&ndash;6.</div><div class="two-column-analysis-style-content-right">Required coverage for reconstructive surgery following mastectomies.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 3&mdash;provisions applicable only to health insurance issuers</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300gg&ndash;11.</div><div class="two-column-analysis-style-content-right">Guaranteed availability of coverage for employers in group market.</div></div>
<div><div class="two-column-analysis-style-content-left">300gg&ndash;12.</div><div class="two-column-analysis-style-content-right">Guaranteed renewability of coverage for employers in group market.</div></div>
<div><div class="two-column-analysis-style-content-left">300gg&ndash;13.</div><div class="two-column-analysis-style-content-right">Disclosure of information.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 4&mdash;exclusion of plans; enforcement; preemption</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300gg&ndash;21.</div><div class="two-column-analysis-style-content-right">Exclusion of certain plans.</div></div>
<div><div class="two-column-analysis-style-content-left">300gg&ndash;22.</div><div class="two-column-analysis-style-content-right">Enforcement.</div></div>
<div><div class="two-column-analysis-style-content-left">300gg&ndash;23.</div><div class="two-column-analysis-style-content-right">Preemption; State flexibility; construction.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part B&mdash;Individual Market Rules</h4>
I74subpart 1&mdash;portability, access, and renewability requirements<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300gg&ndash;41.</div><div class="two-column-analysis-style-content-right">Guaranteed availability of individual health insurance coverage to certain individuals with prior group coverage.</div></div>
<div><div class="two-column-analysis-style-content-left">300gg&ndash;42.</div><div class="two-column-analysis-style-content-right">Guaranteed renewability of individual health insurance coverage.</div></div>
<div><div class="two-column-analysis-style-content-left">300gg&ndash;43.</div><div class="two-column-analysis-style-content-right">Certification of coverage.</div></div>
<div><div class="two-column-analysis-style-content-left">300gg&ndash;44.</div><div class="two-column-analysis-style-content-right">State flexibility in individual market reforms.</div></div>
<div><div class="two-column-analysis-style-content-left">300gg&ndash;45.</div><div class="two-column-analysis-style-content-right">Relief for high risk pools.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 2&mdash;other requirements</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300gg&ndash;51.</div><div class="two-column-analysis-style-content-right">Standards relating to benefits for mothers and newborns.</div></div>
<div><div class="two-column-analysis-style-content-left">300gg&ndash;52.</div><div class="two-column-analysis-style-content-right">Required coverage for reconstructive surgery following mastectomies.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">subpart 3&mdash;general provisions</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300gg&ndash;61.</div><div class="two-column-analysis-style-content-right">Enforcement.</div></div>
<div><div class="two-column-analysis-style-content-left">300gg&ndash;62.</div><div class="two-column-analysis-style-content-right">Preemption.</div></div>
<div><div class="two-column-analysis-style-content-left">300gg&ndash;63.</div><div class="two-column-analysis-style-content-right">General exceptions.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part C&mdash;Definitions; Miscellaneous Provisions</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300gg&ndash;91.</div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
<div><div class="two-column-analysis-style-content-left">300gg&ndash;92.</div><div class="two-column-analysis-style-content-right">Regulations.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="analysis-subhead">SUBCHAPTER XXVI&mdash;NATIONAL ALL-HAZARDS PREPAREDNESS FOR PUBLIC HEALTH EMERGENCIES</h4>
<h4 class="note-head">Part A&mdash;National All-Hazards Preparedness and Response Planning, Coordinating, and Reporting</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300hh.</div><div class="two-column-analysis-style-content-right">Public health and medical preparedness and response functions.</div></div>
<div><div class="two-column-analysis-style-content-left">300hh&ndash;1.</div><div class="two-column-analysis-style-content-right">National Health Security Strategy.</div></div>
<div><div class="two-column-analysis-style-content-left">300hh&ndash;2.</div><div class="two-column-analysis-style-content-right">Enhancing medical surge capacity.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="note-head">Part B&mdash;All-Hazards Emergency Preparedness and Response</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300hh&ndash;10.</div><div class="two-column-analysis-style-content-right">Coordination of preparedness for and response to all-hazards public health emergencies.</div></div>
<div><div class="two-column-analysis-style-content-left">300hh&ndash;11.</div><div class="two-column-analysis-style-content-right">National Disaster Medical System.</div></div>
<div><div class="two-column-analysis-style-content-left">300hh&ndash;12.</div><div class="two-column-analysis-style-content-right">Transferred.</div></div>
<div><div class="two-column-analysis-style-content-left">300hh&ndash;13.</div><div class="two-column-analysis-style-content-right">Evaluation of new and emerging technologies regarding bioterrorist attack and other public health emergencies.</div></div>
<div><div class="two-column-analysis-style-content-left">300hh&ndash;14.</div><div class="two-column-analysis-style-content-right">Protection of health and safety during disasters.</div></div>
<div><div class="two-column-analysis-style-content-left">300hh&ndash;15.</div><div class="two-column-analysis-style-content-right">Volunteer Medical Reserve Corps.</div></div>
<div><div class="two-column-analysis-style-content-left">300hh&ndash;16.</div><div class="two-column-analysis-style-content-right">At-risk individuals.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<h4 class="analysis-subhead">SUBCHAPTER XXVII&mdash;LIFESPAN RESPITE CARE</h4>
<div class="analysis">
<div><div class="two-column-analysis-style-content-left">300ii.</div><div class="two-column-analysis-style-content-right">Definitions.</div></div>
<div><div class="two-column-analysis-style-content-left">300ii&ndash;1.</div><div class="two-column-analysis-style-content-right">Lifespan respite care grants and cooperative agreements.</div></div>
<div><div class="two-column-analysis-style-content-left">300ii&ndash;2.</div><div class="two-column-analysis-style-content-right">National lifespan respite resource center.</div></div>
<div><div class="two-column-analysis-style-content-left">300ii&ndash;3.</div><div class="two-column-analysis-style-content-right">Report.</div></div>
<div><div class="two-column-analysis-style-content-left">300ii&ndash;4.</div><div class="two-column-analysis-style-content-right">Authorization of appropriations.</div></div>
<div><div class="two-column-analysis-style-content-left">300aaa to 300aaa&ndash;13. Transferred.</div></div>
</div>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<!-- field-end:miscellaneous-note -->
<!-- field-end:notes -->


</body></html>